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ABSTRACT 
 
Predicting Treatment Completion: 
A Study of the Federal Bureau of Prisons’ Residential Drug Abuse Program 
 
Y. Tami Yañez 
 
Substance abuse and criminal behavior are two commonly associated social concerns. It is not 
surprising that substance abuse treatment also has demonstrated a reduction not only substance 
abuse, as well as criminal behavior. The Federal Bureau of Prisons’ Residential Drug Abuse 
Program (RDAP) has demonstrated wide-reaching benefits. Understanding the 33% non-
completion rate of RDAP, then, is an important component of the treatment process. This study, 
therefore, sought to identify factors present prior to RDAP participation that may predict 
program completion, which may also guide efforts to reduce relapse and recidivism rates. RDAP 
completers were slightly more likely to have fewer adulthood incarcerations and significantly 
more likely to have longer duration of cannabis use. Non-completers were significantly more 
likely to have shorter current sentences and a trend towards having shorter duration of alcohol 
and amphetamine use. Elevated PAI Drug Problem scale and longer length of current sentence 
were found to help predict RDAP completion. The Psychological Inventory of Criminal 
Thinking Styles (PICTS) was not found to predict RDAP completion. Post-hoc analyses of early 
non-completers versus late non-completers found that early non-completers demonstrated more 
Cluster B characteristics than late non-completers. Future research should examine the 
heterogeneity of non-completers. 
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Predicting Program Completion: 
A Study of the Federal Bureau of Prisons’ Residential Drug Abuse Program 
 
In 2002, an estimated 22-million Americans (9.4 % of the total population of individuals 
ages 12 and older) met diagnostic criteria for substance abuse or dependence (Substance Abuse 
and Mental Health Data Archives, n.d.). According to  reports from the National Center on 
Addiction and Substance Abuse (CASA) in 1996, approximately 80% ($30-billion) of the 
correctional (e.g., jail, prison) expenditures $38-billion budget was spent incarcerating 
individuals with substance-abuse histories or drug-related criminal behavior (as cited in 
McCollister & French, 2002). Given the financial support afforded to substance-abuse programs, 
it is encouraging that client retention in such programs has consistently demonstrated benefits 
beyond decreased rates of relapse. In addition to lower rates of recidivism, completion of 
substance-abuse treatment programs has also been associated with improvements in 
psychological and physical health, as well as an increased rate of post-treatment employment 
(e.g., Bleiberg, Delvin, Croan, & Briscoe, 1994; Condelli & Hubbard, 1994; Leshner, 1997; 
McLellan, Luborsky, O’Brien, Woody, & Druley, 1982; see Nielsen & Scarpitti, 2002). 
 
Although substance-abuse programs have demonstrated short- and long-term benefits of 
retention, drop-out rates range from 44% to 89% (Eisenberg & Fabelo, 1996; Knight, Simpson, 
Chatham, & Camacho, 1997; Ravndal & Vaglum, 1991a) and, thusly, these people (non-
completers) do not experience the wide-ranging benefits of treatment. Therefore, reasons for 
non-completion of treatment have become an important research focus. Therapeutic approach 
(e.g., low intensity, therapeutic alliance) and personal characteristics of the treatment providers 
(e.g., race) has been reported to affect treatment completion (e.g., Kang, Kleinman, Woody, 
Millman, Todd, Kemp, & Lipton, 1991; Kleinman, Moody, Todd, Millman, Kang, Kemp, & 
Lipton, 1990). The substance abuser’s motivation and preparedness to change has also been 
examined with regard to treatment completion (e.g., Hiller, Knight, Broome, & Simpson, 1998). 
Pharmacotherapy has also been studied with regard to the prediction of medication compliance 
and treatment retention (Carroll, Rounsaville, & Gawin, 1991; Gawin, Kleber, Byck, 
Rounsaville, Kasten, & Jatlow, 1989). Additionally, methadone treatment programs have been 
evaluated to assess factors predictive of treatment completion (Saxon, Wells, Fleming, Jackson, 
& Calsyn, 1996; Krebs, Brady, & Laird, 2003). 
 
Prospective studies of individual client characteristics, present at substance-abuse 
treatment intake, which predict program completion is the focus of this review. A study of 
methadone maintenance found treatment retention to be best predicted by older age, non-black 
race, lower Addiction Severity Index (ASI) legal composite scores, higher methadone dose level, 
and participation in programs that did not enforce contingencies for undesirable treatment-related 
behaviors (Saxon, Wells, Fleming, Jackson, & Calsyn, 1996). Krebs, Brady, and Laird (2003) 
also reported that methadone use at jail admission was related to shorter treatment retention. It 
was theorized that this finding may have been a function of the relation between polysubstance 
abuse and poor treatment outcome (DeMaria, Sterling, & Weinstein,, 2000; Lamb, Kirby, & 
Platt, 1996; Rowan-Szal, Chatham, & Simpson, 2000).  
 
Given that pharmacotherapy is not available for all substance addictions and that 
treatment programs tend to be composed of individuals addicted to various substances, studying 
 
  Predicting Treatment Completion     2 
the predictive factors of non-pharmacotherapy substance-abuse treatment programs may prove 
more generalizable to the field of substance-abuse treatment. Therefore, a review of research 
exploring the predictive factors of outpatient, inpatient, and corrections-based treatment program 
completion is warranted. 
 
Retention in Outpatient Programs 
 
 White, Winn, and Young (1998) sought to “identify key predictors” of attrition from an 
intensive outpatient substance-abuse program. Individuals meeting the study’s inclusion criteria 
(i.e., alcohol and/or drug abuse, privately insured or ability to self-pay) participated in 
approximately four weeks of programming, with four to thirteen contact hours per week with a 
counselor. The program primarily utilized a cognitive/behavioral-based treatment approach. A 
“comprehensive intake/assessment package” was administered to participants, however, only 
data from the Addiction Severity Index (ASI) was analyzed in this study, along with basic 
demographic data and family member attendance at family group sessions. Program completers 
ranged in stay from 10 to 64 days, dependant upon extraneous variables (e.g., medical illness) 
necessitating that participants leave treatment and then return at a later time. 
 
Initial discriminant function analyses demonstrated that ASI composite scores and 
severity ratings were not useful predictors of program completion. A subsequent discriminant 
function analysis examined eight ASI items, as well as family involvement in treatment. Results 
suggest that Hispanic ethnicity, absence of a professional skill, shorter time since last 
hospitalization, cocaine or cannabis use in the last 30 days, higher number of family members 
with drug problems, presence of emotional abuse in last 30 days, concern with family problems, 
and low number of family group meetings attended by family members are predictive of poor 
program retention (White et al., 1998). 
 
The Treating Cocaine Abuse (TCA) project was a comparative study of an another 
cognitive-behavioral relapse-prevention program and a recovery support group based on the 
Twelve Steps of Alcoholics Anonymous were the focus of the comparative Treating Cocaine 
Abuse (TCA) project. The first 14 sessions of both programs took place over a 12-week period. 
At 4-week intervals, participants in both programs attended three review sessions, totaling 17 
sessions over a 24-week period. Since results of the initial unpublished study demonstrated there 
were no significant differences in program efficacy or participant demographics, Gainey, Wells, 
Hawkins, and Catalano (1993) combined data obtained from both programs to examine factors 
related to treatment retention among 110 male and female cocaine users in outpatient treatment. 
Treatment retention was operationally defined as attendance of at least eight of the 17 sessions 
offered. Predictor variables were organized into four main categories: (1) social isolation, 
stability, and support, (2) extent of involvement in a drug-using lifestyle, (3) motivation, and (4) 
demographics. All predictor variables were entered into a single logistic regression, controlling 
for all other variables. The model was then reduced, and only those predictor variables which 
were significant at the bivariate or multivariate levels were entered into the equation. A stepwise 
logistic regression resulted in the final predictive model. The resultant predictive factors of living 
alone, prior polysubstance use, length of cocaine use, and external motivation were examined. 
Results of this study indicated that “drop-outs” tended to have used cocaine for a shorter period 
of time and have had a more limited social support network. Finally, “drop-outs” tended to have 
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reported participating in, or have historically been arrested for, more illegal activities prior to 
treatment, with the majority reporting drug-distribution activity (Gainey et al., 1993). 
 
 Predictive factors of completion of a program utilizing the Minnesota Model (i.e., 
intensive outpatient treatment) were explored by Veach, Remley, Kippers, & Sorg (2000). The 
hospital-based program included either 16 or 30 hours of client contact per week (dependent 
upon level of program intensity), with study participants remaining in treatment from one day to 
over 30 days. The following termination statuses were considered as retained in treatment 
(completed treatment):  continuing care, completed treatment, inpatient, another level of care 
with the facility, transferred, and referred out. The following termination statuses were 
considered dropouts:  administrative discharge, against staff advice, cancelled, no show, and 
refused admission.  
 
The following factors were explored for a relation with treatment retention: gender, age, 
employment status, number of problems on treatment plan, DWI related referral, and primary 
DSM-IV substance related diagnosis. Data was collected, ex-post facto, from 509 adult males 
and females who participated in the program over an 18-month period. Utilizing descriptive 
statistics, Wilks Lamda, and univariate F ratios, treatment completers were found to have had 
significantly more treatment-plan problems, were more likely have a diagnosis of alcohol abuse, 
were less likely to have a diagnosis of cocaine abuse, and were more likely to be employed 
during the course of treatment (Veach et al., 2000).  
 
McCaul, Svikis, and Moore (2001) examined predictors of program participation and 
longer retention for 268 patients treated at an urban, hospital-based outpatient substance-abuse 
treatment clinic. Using a multiple regression analysis, substance abuse was not found to predict 
program participation or retention. Rather, clients were more likely to attend more sessions if 
they were Caucasian, male, and had a high pre-treatment employment composite score on the 
ASI. 
 
Prediction of program completion was also examined in a hierarchical therapeutic 
community of 144 substance abusers in Norway (Ravndal 1991a, 1991b; Ravndal and Vaglum, 
1994). The program consisted of a one-year inpatient component described as “intensive, highly 
confrontational, [and] group-oriented.” Following the completion of the inpatient component, 
subjects participated in six months of outpatient treatment consisting of one group meeting each 
week, working as a junior staff in the program (first three months), and regular outside 
employment (last 3 months). At intake, clients were briefly interviewed by staff, administered a 
structured research interview (e.g., sociodemographic data, family background, education, 
employment, substance abuse, legal problems, social adjustment, prior treatment, prostitution 
and sexual assaults), and completed three self-report instruments: Million Clinical Multiaxial 
Inventory (MCMI), Basic Character Inventory, and Symptom Checklist-90. All substance abuse 
was measured as frequency of use during the six months prior to program entry. Only twenty-
nine clients (20%) of the original client sample completed 18 months of the treatment program. 
 
Ravndal (1991b) examined the role of antisocial aggressiveness in predicting completion 
of this program. Clients with higher intake scores on the MCMI antisocial aggression scale 
demonstrated no significant changes in scores over the course of treatment, but had a higher rate 
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of non-completion (45%) of the out-patient component of the program than did clients with 
lower MCMI antisocial aggressions scores that increased over the course of treatment.  
 
 Ravndal (1994) also examined the predictive power of depression with regard to program 
completion in the same hierarchical 1-year inpatient/6-month outpatient therapeutic community. 
In addition to the same subject pool and methods of data collection utilized in the previous study 
were employed, data from 36 drug-free clients were included. Utilizing a logistic regression, it 
was found that depression did not predict non-completion of the inpatient phase of treatment. 
Depression did emerge as a predictive factor after one year of treatment, however, depressed 
clients were five time more likely to drop out of the out-patient treatment program. 
  
Retention in Inpatient Programs 
 
 Ravndal (1991a) also examined the predictive power of psychopathology and substance 
abuse with regard to completion of the in-patient phase of the 18-month program. Forty-three 
(30%) of the original 144 subjects completed the inpatient component of the program. A logistic 
regression was utilized to examine predictive power of amphetamine use, alcohol use, gender, 
and psychopathology with regard to inpatient and total program completion. Ravndal and 
Vaglum (1991a) report pre-admission use of alcohol and amphetamine were the most powerful 
predictors of inpatient treatment completion. Completion of the 18-month total program was best 
predicted by gender (female), higher frequency of histrionic traits, and a lower frequency of 
schizotypal traits, as compared to non-completers.  
 
Predictors of residential program completion among pregnant women, or women who 
entered treatment with their children were examined by Knight, Logan, and Simpson (2001). The 
Salvation Army’s First Choice Program (First Choice) is a 12-month residential program for 
women with dependent children. The Initial Self-Rating Form and an extensive 90-minute intake 
interview were completed prior to the beginning treatment. Specifically, data was collected on 
sociodemographic variables, substance use, legal involvement, psychological functioning, and 
social relations. At discharge, completion status was determined based on sufficient length of 
stay (i.e., 6 months), personal progress toward treatment goals, and being in good standing with 
the agency. Utilizing a multivariate prediction model, women who completed program 
requirements were more likely to have at least a high school diploma or GED, no arrests in the 
six months prior to admission, and reported having fewer socially deviant peers. Additionally, 
the authors note that marital status, number of dependent children, child welfare involvement, 
cocaine use, and depression, while not statistically significant predictors, demonstrated a strong 
relation to program completion (Knight et al.).  
 
Retention in Corrections-Based Programs 
 
Substance-abuse treatment within correctional settings has historically received limited 
empirical attention (Leukefeld, Matthews, & Clayton, 1992). One reason for the limited study of 
program retention among prisoners may be a misconception that inmate participation in 
corrections-based treatment programs is mandatory and completion of the program is strictly 
enforced. Often times, however, it is only recommended, and not required, that prisoners 
participate in corrections-based programming. Different types of reinforcements are incentives to 
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participate (e.g., early release), but ultimately the prisoner decides what type and intensity of 
programming he or she will complete.  
 
A recent study by Nielsen and Scarpitti (2002) improved this research area by 
simultaneously examining different types of predictive factors of program completion. Data from 
the first five years of CREST Outreach Center’s operation was examined. CREST is a residential 
community-based therapeutic community lasting approximately six months for prison inmates 
with histories of substance abuse.  
 
Nielsen and Scarpitti (2002) examined seven categories of independent variables. First, 
demographic/background factors included gender, race, education, age, marital status, and 
number of children. Second, criminal history included whether an inmate’s instant offense was a 
property offense, a violent offense, or a drug-related offense, or “other,” and at what age the 
inmate was first arrested. Third, prior substance abuse was measured by frequency of marijuana 
use, cocaine use, and crack use. Additionally, the presence of a history of heroin use was 
included. Fourth, a history of substance-abuse treatment was recorded for each inmate. Fifth, 
motivation and readiness were examined by whether or not the inmate considered him/herself an 
“addict,” and an inmate’s “drug-use plans for the next year”. Sixth, psychological factors (i.e., 
obsession-compulsion, depression, anxiety, interpersonal sensitivity, paranoid ideation, hostility, 
and self-esteem) were assessed using the Revised Symptom Checklist-90 (SCL-90R; Derogatis, 
1977). Finally, an inmate’s legal pressures to attend treatment were examined. They utilized two 
dependent variables: completion and days in treatment. Completion was operationally defined as 
whether the client addressed major treatment issues, modeled appropriate behavior and attitude, 
and obtained employment. Non-completion of the program was determined by a voluntary return 
to prison in lieu of continuing CREST, or those who returned to prison as a result of expulsion 
from CREST for severe rule violations.  
 
Utilizing a logistic regression analysis and an ordinary least squares regression, the 
simple variable of “frequent marijuana use prior to treatment” best predicted program completion 
and days in treatment, respectively. When examining only program completion, inmates with 
higher levels of education and higher levels of obsession-compulsion were more likely to 
complete CREST.  
 
Residential Drug Abuse Program and Relevant Research 
 
Theories of Criminality 
 
Understanding criminal behavior has been the focus of sociological theorists for many 
years. The ecological perspective of criminality (also termed Chicago school) contains three 
primary theories (Whitehead & Lab, 1999). The concentric zones theory and delinquency areas 
theory posit that geographic factors contribute to criminality. The social areas theory, however, 
suggests that social characteristics of individuals concentrated in an area create an environment 
susceptible to crime. The sociological learning perspective of criminality examines the role of 
social learning as it relates to criminality (Whitehead & Lab). For example, Sutherland’s 
differential association theory simply posits that individuals learn from direct social contact with 
others; therefore, contact with deviant peers results in deviant behavior by the target individual, 
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whereas others suggest that deviant social learning can also take place via indirect contact (e.g., 
media). Additionally, a process of operant condition takes place when individuals witness 
favorable outcomes for other individuals engaging in deviant behavior. The subculture 
explanations of criminality explore the effect of social status and social group norms with regard 
to criminal behavior (Whitehead & Lab). Conversely, sociologists such as Durkheim and Merton 
offer social control theories to examine the inhibiting effects of social factors with regarding to 
criminal behavior. Social structure is also the focus strain theory. Specifically, it is theories that 
that anomie, or normlessness, causes social chaos resulting in individual means and goals 
incongruence (Whitehead & Lab, 1999). 
 
The lifestyle model of criminal conduct (Walters & White, 1989) theorizes that criminal 
behavior results from the interaction of three primary factors termed the “three Cs”. First, 
conditions include internal (e.g., heredity, intelligence), external (e.g., family, peers), and 
interactive (e.g., person x situations) components which may expand or inhibit a person’s life 
options. Individuals then have the opportunity to make a choice of the available life options. As a 
result of various choices made, the individual may then come to alter their cognitions to decrease 
potential cognitive dissonance which may arise. It is further theorized that the “three Cs” merge 
over time, to create a dynamic and multidirectional system of interacting behavioral influences 
that retains the role of individual differences. It is this lifestyle model of criminal conduct that 
the Federal Bureau of Prisons’ Residential Drug Abuse Program is based upon. 
 
Bureau of Prisons’ Residential Drug Abuse Program 
 
Established in 1990, the Residential Drug Abuse Program (RDAP) focuses not only on 
substance abuse, but on the criminal lifestyle as well. RDAP is currently in operation in 42 
Bureau of Prison (BOP) institutions, including Federal Prison Camps, Federal Correctional 
Institutions, and Federal Medical Centers. This three-phase voluntary treatment program was 
designed with the end goal of reducing both post-release relapse and recidivism. All RDAP 
participants must satisfy four eligibility criteria: (1) he/she meets DSM-IV diagnostic criteria for 
alcohol or illegal/illicit drug use or dependence disorder and a records review supports this 
diagnosis, (2) he/she has no serious mental impairment that would substantially interfere with or 
preclude full program participation, (3) he/she signs the agreement to participate in RDAP, (4) 
generally, he/she is within 36 months from release from the BOP.  
 
Participation in this program may be voluntary or court recommended. Inmates 
participating in the intensive residential treatment (Phase One) of RDAP are assigned to the 
treatment-designated housing unit at the institution. Participants are then organized into groups 
of approximately 30 inmates with similar projected release dates. Participation in RDAP consists 
of structured group treatment or activities for approximately 3 hours each day, five days each 
week, for 6-, 9-, or 12-months (i.e., ranging from 300 to 700 hours in treatment). While the 
length of programs may vary across institutions, a standard treatment package is consistent 
across RDAP sites in accordance with BOP policy. 
 
Phase One was established upon the premises that the inmates are responsible for their 
behaviors and they are able to change those behaviors. In accordance with these premises, Phase 
One consists of five general skill-building approaches. First, Rational-Emotive/Rational-
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Behavior Therapy is designed to teach inmates to distinguish rational from irrational beliefs. 
Further, inmates are encouraged to understand the impact of personal beliefs on their behavior.  
 
Second, Errors in Thinking focuses on reframing eight common criminal thinking errors, 
as adapted from Yokelson and Samanow’s 52 thinking errors (1986) and related to the cognitive 
component of the lifestyle model of criminal conduct. The first of the eight errors, mollification, 
is the thinking style utilized when a criminal justifies and rationalizes his or her norm-violating 
behavior by focusing on social injustice, minimizes the seriousness of specific antisocial acts, or 
projects blame onto the victims of his or her crimes. The second thinking error, cutoff, is 
characterized by a quick elimination of fear, anxiety, and other psychological deterrents to 
criminal behavior. Entitlement, the third thinking error, takes place when the criminal displays a 
misconception of ownership, privilege, and lacks the ability to distinguish between “needs” and 
“wants”. Fourth, the thinking error of power orientation is when the individual engages in 
outward displays of aggression in a self-serving attempt to control or manipulate others. Fifth, 
the thinking error of sentimentality is characterized by performing seemingly selfless good deeds 
in a purposeful and premeditated attempt to seek forgiveness for past criminal behaviors. 
Superoptimism, the sixth thinking error, is the criminal’s tendency to overestimate chances of 
avoiding negative consequences of criminal behaviors. “Lazy thinking, short-cut problem 
solving, and uncritical acceptance of personal ideas and plans” characterize the seventh criminal 
thinking error of cognitive indolence (Walters, 1995, p. 309). Finally, the discontinuity style of 
thinking suggests minimal premeditation in cognitions, resulting in a tendency not to follow 
through on initially good intentions. Additionally, RDAP participants are encouraged to develop 
honesty, tolerance, respect, and responsibility.  
 
Third, Communication and Interpersonal Relationships Skill-Building consists of lessons 
intended to improve communication skills, family relationships, and emotions. Specifically, 
inmates are instructed in appropriate assertiveness skills, empathy, coping with emotions, and the 
relation between their own childhood experiences and their past and future parenting skills. 
Fourth, Relapse Prevention and Wellness consists of the development of individual relapse-
prevention plans, including the effectiveness of physical exercise, to be utilized while at the 
institution and after release. Finally, Release Planning teaches concrete community-living skills 
such as securing employment, housing, and medical attention. Additionally, coping with issues 
related to re-entering society as a felon are addressed. 
 
Successful completion of RDAP may result in as much as one-year decrease in time 
incarcerated, dependant upon individual qualification (e.g., non-violent offense, absence of a 
weapon during commission of instant offense). While the institution-based Phase One of RDAP 
is the focus of the proposed project, it should also be noted that, following the completion of the 
intensive residential treatment program, inmates participate in the Transitional Services portion 
(Phase Two) of the program. During Phase Two, inmates are required to attend one meeting per 
month, for up to 12-months, at the institution prior to their release. Finally, the Community 
Aftercare portion (Phase Three) lasts for a maximum of 6-months, consisting of outpatient, 
community-based drug abuse treatment at a half-way house near the offender’s home 
community.  
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Over the past 20 years, the United States federal prison population has rapidly increased 
with approximately 68% of the increase accounted for by drug-law violators (McCollister & 
French, 2002). In 1997, an estimated 50% of all federal inmates reported using drugs in the 
month prior to committing their offense (Bureau of Justice Statistics (BJS), 1999), and up to 80% 
of inmates admit to drug use in their lifetime (BJS; National Center on Addiction and Substance 
Abuse (CASA), 1998). Currently, 53.8% of the 182,101 federal prison population of men and 
women are convicted of drug-related offenses (Federal Bureau of Prisons, 2005).  
 
 Given the increase in the number of inmates with documented drug-related problems, 
participation in the Drug Abuse Program (DAP) within the BOP has also steadily increased, with 
more than 10,000 inmates nationwide currently participating in RDAP. Additionally, Langan and 
Pelissier (2001) reported graduates of the Federal Bureau of Prisons’ substance abuse treatment 
programs are 74 % less likely to engage in misconduct over a 14-month post-treatment period of 
incarceration. 
 
Information released by the BOP and National Institute on Drug Abuse in 1998, shows 
completion of RDAP significantly decreases criminal behavior in ex-inmates. Specifically, as 
compared to released inmates who did not participate in RDAP, six months following release, 
RDAP completers are 73% less likely to be re-arrested and 44% less likely to resume drug use. 
Further, the Office of National Drug Control Policy reports a recidivism rate of 3.3% within six 
months after release from prison for inmates completing RDAP, as compared to 12.1% for non-
treated inmates (as cited in McCollister & French, 2002). 
 
Retention in the Residential Drug Abuse Program 
 
The BOP initiated an empirical investigation of the drug-abuse treatment provision 
within the BOP and its efficacy. The Treating Inmates Addicted to Drugs (TRIAD) study is a 
three-year outcome design of male and female inmates within the BOP (Pelissier, 2000). 
Treatment entry and completion was one focus of the TRIAD study. Researchers collected 
background information and administered the Change Assessment Scale, DSM-III-R automated 
Diagnostic Interview Schedule for depression and antisocial personality disorder, and Hope 
Scale to inmates who were eligible for treatment but did not enter, those who entered treatment 
but did not complete the program (802 men, 292 women), and those who completed treatment 
(932 men 193 women). For males and females, treatment completion was positively associated 
with current offenses of greater severity, no lifetime diagnosis of depression or Antisocial 
Personality Disorder (ASP), and higher maintenance factor scores of the Change Assessment 
Scale. Also, for both males and females, treatment completion and was less common among 
those with higher precontemplation factor scores at pre-treatment. Furthermore, for men, 
treatment completion was positively associated with older age at current commitment, plans to 
live with children who are minors after release, and higher contemplation scores. Also, for men, 
treatment completion was negatively related to a recent history of a violent offense, longer 
sentence lengths, average or good family ties, prior drug treatment, and not benefiting from the 
sentence-reduction provision. 
 
Pelissier, Camp, and Motivans (2002), utilizing a sub-sample (1,446 male and female 
inmates) of the TRIAD sample, examined predictive factors of treatment retention in twenty 
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BOP RDAPs. Researchers conducted individual background interviews to collect information on 
basic demographic data, history of violence, and substance-abuse history. Additionally, the 
DSM-III-R Diagnostic Interview Schedule (DIS) modules for ASP and depression were 
administered. Finally, motivation was measured via the Change Assessment Inventory and 
whether the inmate would benefit from the sentence-reduction provision. Disciplinary discharges 
were found to be more common among younger inmates, those with a history of violence, and 
those with a lifetime diagnosis of ASP. RDAP non-completion due to the inmate’s withdrawal 
from the program was less common among men and those individuals with higher levels of 
motivation for change. Pelissier and colleagues recommended that the results of this study may 
support the denial of acceptance into RDAP where treatment resources are limited until the 
“individual meets a minimal threshold”. 
 
In a related BOP report, Pelissier (in press) examined 1,489 RDAP participants and 740 
non-treatment (comparison) participants. The following data was collected for each inmate: 
demographic, criminal history, employment status, family background, substance-abuse history, 
and eligibility to benefit from the sentence-reduction provision. Additionally, all inmates were 
administered the DSM-III-R DIS modules for ASP and depression, the Change Assessment 
Scale, Hope Scale, and Ways of Coping Questionnaire. Race and ethnicity were not related to 
treatment entry or retention. Among males and females, treatment completion was found to be 
positively related to greater severity of current offense and no lifetime diagnosis of ASP. For 
males, older age, stronger family ties, and plans to live with children who are minors upon 
release were positively related to treatment completion. A recent history of perpetrating violence, 
longer sentences, prior drug-abuse treatment, and ineligibility to benefit from the sentence-
reduction provision were negatively associated with treatment completion among men. Several 
factors of the Change Assessment Scale were also found to be related to treatment completion. 
Specifically, men and women with higher precontemplation scores were less likely to complete 
treatment, while those with higher maintenance scores were more likely to complete treatment. 
Finally, men with higher contemplation scores were more likely to complete treatment. 
 
Summary of Predictive Variables 
 
Demographic Variables  
 
Demographic variables historically found to predict program retention may be divided 
into five categories: age, race/ethnicity, education, substance abuse (i.e., abuse history and 
treatment history) and criminal history.  
 
Age. First, replication of the predictive power of age has been demonstrated in several 
retention studies of outpatient, inpatient, and corrections-based treatment programs. The relation 
between age and retention, however, has shown mixed results. For example, some researchers 
have demonstrated younger participants fair better in treatment programs (Gainey, Wells, 
Hawkins, & Catalano, 1993). One reason may be that younger individuals may have a shorter 
history of risky behavior and, thus, more amenable to change. Others, however, report that older 
participants are more likely to complete treatment programs (Krebs, Brady, & Laird, 2003; 
Saxon, Wells, Fleming, Jackson, & Calsyn, 1996; Pelissier, 2000; Pelissier, Camp, & Motivans, 
2002; Pelisser, in press). This finding may suggest that their history of substance-abuse-related 
 
  Predicting Treatment Completion     10 
negative experiences may serve to convince the individual that treatment is necessary at this time 
in order to prevent future difficulty (e.g., physical ailments, legal problems, family problems).  
 
Race/Ethnicity. The impact of an individual’s ethnicity on program completion has also 
produced mixed empirical data. Pelissier (in press) found no association between race/ethnicity 
and program completion. Others, however, have demonstrated a negative relationship between 
non-white clients and program completion (White et al., 1998; Saxon, Wells, Fleming, Jackson, 
& Calsyn, 1996).  
 
Education. Third, educational level has been shown to predict program completion. 
Specifically, individuals with at least a high school diploma or GED (Knight et al., 2001; Nielsen 
& Scarpitti, 2002) appear to do better in substance-abuse treatment programs, while the absence 
of a professional skill appears to negatively affect program completion (White et al., 1998). A 
related factor, participant intelligence, has not been examined as a predictive factor of program 
completion.  
 
Substance Abuse History 
 
 Abuse History. An individual’s history of substance abuse may be described in two 
categories. First, an individual’s abuse or dependence of specific substances has demonstrated 
predictive power of program retention. Specifically, higher rates of program retention have been 
associated with a primary diagnosis of alcohol abuse or dependence (Veach, Remley, Kippers, & 
Sorg, 2000; Ravndal & Vaglum, 1991a), amphetamine abuse or dependence (Ravndal & 
Vaglum, 1991a), and cannabis abuse or dependence (White et al., 1998; Nielsen & Scarpitti, 
2002). The evidence of the predictive power of cocaine abuse or dependence is conflicting. Some 
have demonstrated that cocaine abuse or dependence is predictive of program completion (White 
et al., 1998; Knight et al., 2001), while others report individuals addicted to cocaine were less 
likely to complete substance-abuse treatment programs (Veach, Remley, Kippers, & Sorg, 2000).  
 
The second category under history of substance abuse is the severity or duration of abuse. 
Completion of outpatient cocaine-abuse treatment was found to be negatively affected by a less 
extensive history of cocaine abuse (Gainey et al., 1993). As with age, a possible explanation for 
this finding may be that individuals with longer histories of abuse may have experienced greater 
drug-related personal difficulties and may have attempted treatment programs/recovery more 
times in the past. Additionally, individuals with generally more severe substance-abuse problems 
(e.g., polysubstance abuse, length of abuse) tend to have greater difficulty completing substance-
abuse treatment programs (e.g., Wickizer, Maynard, Atherly, Fredrick, Koepsell, Krupski, & 
Stark, 1994).  
 
Treatment History. Prior treatment history has consistently been negatively associated 
with current program completion (e.g., Pelissier, 2000; Pelissier, in press). It is likely, however, 
that having participated in prior treatment programs does not render an individual less apt to 
complete future programs. Rather, it appears more likely that relapse after participation in prior 
treatment programs, resulting in the need for the current treatment program, decreases an 
individual’s chance at completing the current program.  
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Criminal History  
An individual’s criminal history has consistently been negatively associated with 
program completion. A more extensive criminal history (Gainey et al., 1993), history of violent 
offenses, severity of current offense, and longer current sentence are negatively associated with 
program completion (Pelissier, 2000; Pelissier, Camp, Motivans, 2002; Pelissier, in press). It is 
suggested that a more sustained criminal lifestyle may be accompanied by a variety of 
intraindividual and interpersonal expectations that may hinder an individual’s ability or 
motivation to complete substance abuse treatment.  
Psychological Factors  
 
The relationship between psychological problems and completion of treatment has been 
the focus of several retention studies. Program completion has been positively associated with a 
higher frequency of histrionic personality characteristics (Ravndal & Vaglum, 1991a) and 
obsessive-compulsive tendencies (Nielsen & Scarpitti, 2002). Lower levels of schizotypal 
characteristics have also been associated with treatment retention (Ravndal & Vaglum, 1991a). 
Depressed clients, however, have demonstrated significant difficulty in the completion of 
substance-abuse treatment (Ravndal, 1994; Knight et al., 2001). Poor treatment retention has also 
been associated with higher levels of antisocial aggression (Ravndal, 1991b) and a diagnosis of 
Antisocial Personality Disorder (Pelisser, 2000; Pelissier, Camp, & Motivans, 2002; Pelissier, in 
press).  
 
A related aspect of criminality that has not been explored is a cognitive component. 
Theoretically associated with criminal behavior, as described by Yokelson and Samenow (1974, 
1986), individuals demonstrate a network of thinking styles and/or errors that are theorized to 
categorize individuals on a continuum of responsibility. On this continuum, the “severe criminal” 
takes the least responsibility for the behavioral effects of his or her maladaptive cognitions. Thus, 
criminal thinking styles are associated with more extensive criminal behavior (Yokelson & 
Samenow, 1974, 1986). Further, extensive criminal behavior has been associated with higher 
drop-out rates (Gainey et al., 1993; Knight et al., 2001). Therefore, one may extrapolate that 
criminal thinking styles may be associated with drop-out rates as well. 
 
Purpose 
 
The purpose of the proposed project, then, is multi-faceted. This project increases the 
understanding of individual factors that are indicative of a poor probability of completing RDAP. 
Guided by this information, treatment planning may be tailored to target specific aspects of an 
individual’s clinical presentation, while retaining the structure of RDAP. As a result, the current 
Phase One RDAP completion rate of 67% at FCI Morgantown (Baker & Koch, personal 
communication, September 28, 2003) may increase. It would follow that subsequent decreases in 
relapse and recidivism rates may occur amongst RDAP completers from FCI Morgantown. 
Further, understanding factors associated with RDAP completion at FCI Morgantown will likely 
benefit BOP RDAPs nationwide. 
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Design 
 
 This is a two-group design study of predictive factors of program completion. Pre-
treatment data obtained from members of both groups, completers and non-completers, were 
analyzed to explore predictive ability. 
 
Hypotheses 
 
 The following hypotheses are primarily based on the available literature of prediction of 
substance abuse program retention/completion. Hypotheses are organized by type of variable: 
demographic, substance use history, criminal history, psychological/cognitive styles. 
 
Univariate Prediction  
 
Hypothesis One. It is hypothesized that older age, higher IQ, and higher level of 
education will be positively associated with program completion.  
 
Hypothesis Two. It is hypothesized that a longer history of cocaine, heroin, and alcohol 
abuse will be positively associated with program completion. A shorter history of marijuana is 
hypothesized to be negatively associated to program completion.  
 
Hypothesis Three. It is hypothesized that number of incarcerations will demonstrate a 
positive relationship to program completion, while history of violent offenses will be negatively 
associated with program completion.  
 
Hypothesis Four. It is hypothesized that depressed mood, antisocial characteristics, and 
schizotypal symptoms (as measure by the PAI) will be negatively associated with program 
completion.  
 
Hypothesis Five. It is hypothesized that the PICTS criminal thinking styles of 
mollification, entitlement, and superoptimism will be negatively associated with program 
completion. 
  
Multivariate Prediction 
 
 Hypothesis Sixe. It is hypothesized that older age, more extensive substance abuse and 
criminal histories, and the criminal thinking styles of entitlement and mollification will emerge 
as significant predictors of program completion. 
 
 Hypothesis Seven. It is hypothesized that significant predictive factors will correctly 
classify program completers versus non-completers beyond the probability of chance. 
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Methods 
 
Research Setting 
The Federal Correctional Institution in Morgantown, WV (FCI Morgantown) is a 
minimum-security male correctional facility. Inmates who have approximately 36 months 
remaining on their sentence, a substance-abuse history documented in their Pre-sentencing 
Investigation report (PSI), and meet DSM-IV diagnostic criteria for drug or alcohol abuse or 
dependence are eligible to participate in the RDAP. The residential component of RDAP at FCI 
Morgantown consists of structured treatment programming, in accordance with BOP policy, 
lasting nine months (approximately 500 hours). Inmates attend RDAP group meetings five days 
each week, approximately three hours each day and reside in the housing unit designated only for 
inmates currently participating, or awaiting participation, in RDAP.  Number of sessions and 
hours of treatment vary slightly by cohort, as well as within each cohort, due to extraneous 
variables (e.g., federal holidays, inmate illness, and conflicting institutional appointments for 
inmates).  
 
Participants 
 
Inmates meeting eligibility requirements are assigned to an RDAP treatment group based 
on the length of sentence remaining to be served. Approximately 30 inmates are assigned to each 
group. As a component of individualized treatment planning, within the first two weeks of 
treatment, inmates assigned to each group are administered a battery of psychological assessment 
instruments during two four-hour group meetings. Data from nine consecutive RDAP groups at 
FCI Morgantown was included in the current study.  
 
Program “completers” were defined as those inmates who complete the 9-month RDAP 
group to which they were initially assigned. Program “non-completers” were inmates who 
started an RDAP group but did not complete with their cohorts due to a clinical decision to 
restart the inmate in a later RDAP group due to poor treatment progress, clinical decision to 
remove the inmate from RDAP due to poor therapeutic progress, or an inmate’s decision to 
withdraw from the RDAP. Data obtained from four inmates who did not complete RDAP as a 
result their removal from the institution due to reasons outside of RDAP regulations (e.g., writ of 
habeas corpus, medical transfer) was excluded from analyses. Additionally, seven inmates were 
excluded from this original sample due to incomplete data sets. The final study sample consisted 
of 254 male inmates, with a 67.7% completion rate (172 completers, 82 non-completers) at FCI 
Morgantown.  Completers averaged 169 sessions over the nine-month program, with an average 
of 509 hours of treatment programming. Non-completers averaged 80 sessions, and averaged 234 
hours of treatment programming.   
 
Basic Demographics. Basic demographics are summarized in Table 1. The mean age of 
RDAP participants was 36.15 (SD=9.87). 53.9% self-identified as African-American, 34.6% as 
Caucasian, 7.5% as Hispanic-American, 1.6% as Asian-American, 1.6% as Native American, 
and .8% as other (i.e., Egyptian, Bi-racial). The average education for this sample was 12.09 
years (SD=2.13). The majority (51.2%) of the sample are Single/Never-married, 30.7% are 
Married/Common-law, 14.6% are Divorced, and 3.5% are Separated. Mean number of known 
biological children was 1.95 (SD=1.80).  
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 Substance-Abuse Data. Substance abuse data are summarized in Table 1. Ten categories 
of substances found in the Diagnostic and Statistical Manuel of Mental Disorders – Fourth 
Edition (DSM-IV) were employed in the current study to aid in the categorization of drug-use 
history.  The average length of time each category of drug was abused are as follows: alcohol for 
15.94 years (SD = 10.66), amphetamine for 2.28 years (SD = 4.88), cannabis for 12.42 years 
(9.78), cocaine for 5.32 years (SD = 7.56), hallucinogens for 1.19 years (SD = 3.82), opiates for 
1.43 years (SD = 4.12), sedatives for 1.35 years (SD = 4.15), and inhalants, phencyclidine, and 
other drugs for fewer than one year.  Voluntary and involuntary inpatient and outpatient 
treatment history was negligible, with the sample participating in an average of less than one 
program prior to current RDAP participation.   
 
Criminal History Data. Criminal history data are summarized in Table 1. RDAP 
participants were asked to estimate the number of state and federal incarcerations as an adult. 
Reports ranged from one to thirty-three, with the mean number of incarcerations being 2.33 
(SD=2.66). A maximum of 164 months of incarceration as an adult was reported and the mean 
number of months of incarceration was 36.61 (SD=35.09). Current sentence ranged from twelve 
months to 216 months (M=60.96, SD=37.69).  Drug offenses accounted for 88% of the sample’s 
current incarcerations.  
 
Measures 
 
 Data utilized in the current project was sampled from a larger data pool compiled during 
an ongoing treatment-planning process of RDAP at FCI Morgantown. For the purposes of the 
current study, however, data from four psychological instruments was analyzed (Table 2), in 
addition to a review of records. All identifying data was removed from assessment data included 
in the current study.  
 
General Ability Measure for Adults (GAMA; Naglieri & Bardos, 1997). Inmate’s 
intelligence was measured by the GAMA. This is a timed (25 minutes), nonverbal evaluation of 
general intellectual ability that may be administered in a group setting. Administration stimuli 
include a response sheet and a test booklet of colorful designs (designed to minimize the effects 
of color-blindness) which the test-taker examines and to which the test-taker responds. Four 
sample items are provided and explained by the test administrator to ensure understanding of the 
GAMA instructions. During the actual test administration, no assistance may be offered by the 
test-administrator. Directions for each item are written at an early elementary reading level 
(grade 2.4). The 66 items of the GAMA are organized into four subtests. First, the matching 
subtest requires the test-taker to examine shapes and colors, with the end goal of deciding which 
design option is identical to the target design. The analogies subtest involves understanding the 
relationships in a pair of abstract figures, with the end goal of recognizing a similar option in a 
different pair of figures. Third, the sequences subtest involves the analysis of the 
interrelationships of designs, with particular attention to the spatial and sequential aspects of the 
designs. Finally, the construction subtest involves the “analysis, synthesis, and rotation of spatial 
designs,” with the end goal of completing the established pattern with one of the design options.  
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Conversion of tallied subtest scores yields the GAMA IQ score, percentile, and 
confidence intervals. As is used with many tests of intelligence, GAMA IQ scores range from 43 
to 156, have a mean of 100, and a standard deviation of 15. Subtest scale scores have a mean of 
10 and a standard deviation of 3. The GAMA was standardized on a nationally representative 
sample (according to the 1990 U.S. Census) of 2,360 adults ranging from 18-years-old to 96-
years-old. Average reliability coefficients range from .66 to .81 across age groups. Internal 
consistency of the GAMA IQ score was found to be slightly higher, with an average reliability 
coefficient across age groups of .90 (Naglieri & Bardos, 1997). The GAMA IQ score has also 
demonstrated good correlations with WAIS-R Verbal IQ (.65), WAIS-R Performance IQ (.74), 
WAIS-R IQ (.75), K-BIT Vocabulary (.54), K-BIT Matrices (.72), and K-BIT IQ (.70).  
 
Personality Assessment Inventory (PAI: Morey, 1991). Inmates’ psychological symptoms 
were measured by the PAI. This is a 344-item, non-overlapping multi-scale personality test 
(Attachment A). The self-report format of the PAI allows for group administration. Responses to 
items are on a 4-point Likert-type scale, ranging from “Not True” to “Very True”. The PAI 
contains four validity scales, including Negative Impression Management (NIM), Positive 
Impression Management (PIM), Inconsistency (INC), and Infrequency (INF). Elevations of T-
scores (≥ 65) on any of the validity scales suggest dishonest responding and render the PAI 
profile invalid and uninterpretable. The PAI also consists of 11 clinical scales: somatic 
complaints, anxiety, anxiety-related disorders, depression, mania, paranoia, schizophrenia, 
borderline features, antisocial features, alcohol problems, and drug problems. For the clinical 
scales, T-scores of 70 and higher are interpreted as significant for a clinical sample. The PAI has 
been well validated. See PAI manual for review of extensive validation research. 
 
Paulhus Deception Scales (PDS; Paulhus, 1998). Potential dishonest responding by 
inmates were measured by the PDS. This 40-item self-report measure of social desirability is 
written at a 5th-grade reading level. PDS items are responded to on a 5-point Likert-type scale, 
ranging from “Not True” to “Very True” (Appendix B). The PDS consists of two 20-item scales: 
Impression Management (IM) and Self Deceptive Enhancement (SDE). The IM scale measures 
the degree to which the responder is attempting to make a positive or favorable impression in 
responses to the tests. Elevation of the IM scale is suggestive of deception and manipulation 
when elevated. The SDE scale measures both a generalized personality bias toward 
overconfidence and a tendency to minimize personal weaknesses. Elevation of the SDE scale is 
suggestive of defensiveness and, when extremely elevated psychopathy should be considered. A 
low SDE score may also indicate depression (true or feigned) in the responder. For the purposes 
of the current study, the Total PDS score was used in analyses to measure overall dishonest 
responding. 
 
Data supporting the reliability and validity of the PDS is offered in the administration 
manual. On a sample of 603 “prison entrants”, good internal consistency of the SDE scale (.72), 
IM scale (.84), and Total score (.86) were reported. Convergent and discriminant validity of the 
PDS are supported by reviews of nine studies in the administration manual. 
 
Psychological Inventory of Criminal Thinking Styles (PICTS; Walters, 2001). The PICTS 
is an 80-item self-report measure developed within the BOP and primarily validated on 
corrections populations (White & Walters, 1989; Walters & White, 1989; Walters, 1995a; 
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Walters, 1995b; Walters, 1997; Walters, Elliot, & Miscoll, 1998) (Appendix C). The eight 
criminal thinking styles examined by the PICTS are those targeted by RDAP and hypothesized to 
proceed and sustain a criminal lifestyle (Walters & White, 1989), as adapted from Yokelson and 
Samenow’s (1976) thinking errors. T-scores of 60 or higher on any of the PICTS eight content 
scales are considered elevated. It has been reported, however, that offenders with a drug-abuse 
history tend to elevate the PICTS thinking style scores beyond that achieved by offenders with 
no personal history of drug abuse (as cited in Walters, 2001). All eight criminal thinking styles 
were included in primary analyses, and were considered for inclusion in secondary analyses, to 
explore their relationship with program completion. The PICTS is a relatively new psychological 
instrument with related empirical studies conducted primarily by the PICTS’ author. Validity 
data is emerging. 
 
Review of Relevant Records. Review of each RDAP participant’s arrest record via the 
BOP computerized record system (SENTRY) was utilized to acquire official information on 
criminal history (i.e., number of incarcerations, history of violent offenses). The RDAP 
eligibility interview will be reviewed to obtain information on each inmate’s history of substance 
abuse (i.e., duration of abuse of specific illegal substances). 
 
Procedure 
 
At FCI Morgantown, RDAP group members are administered a battery of psychological 
assessment instruments. This assessment process is conducted in a group setting during two four-
hour group meetings within the first two weeks of treatment. This data is used in assisting RDAP 
treatment providers to individualize treatment plans and gain a better understanding of group 
members’ psychological and behavioral histories. The assessment process was conducted by the 
author for the primary purpose of treatment planning within RDAP. Data analyzed in this study, 
therefore, was largely archival, with the exception of treatment completion status and substance-
abuse history. Information regarding substance-abuse history was collected via review of each 
inmate’s RDAP eligibility interview. Eligibility interviews are routinely conducted by RDAP 
staff prior to each inmate’s enrollment in RDAP.  
 
Analytic Plan 
 
Univariate and Bivariate Analyses 
 
 As a first step, intercorrelations among all study variables were explored. Those variables 
found to be strongly correlated were examined to determine whether a reduction in total 
variables is warranted due to multicollinearity (i.e., highly correlated variables which may be 
found to measure the same construct). Next, a one-way analysis of variance (ANOVA) was 
conducted to explore whether dishonest responding, as measured by the Paulhus Deception Scale 
total score (PDS-Total), was significantly different between completers and non-completers. 
There was a significant difference completion status on PDS-IM (F(1,252) = 4.311, p < .05), but no 
significant difference emerged for completion status on PDS-SDE (F(1,252) = 1.057, p = .747). 
There was not a significant effect of completion status on PDS-Total (F(1,252) = 1.649, p = .200). 
Mean PDS-Total for completers was 8.76 (SD=5.79) and for non-completers was 7.90 
(SD=4.57). Given that interpretation of the PDS uses the evaluation of “higher” and “lower” 
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scores, no subsequent analyses (e.g., Chi-square analyses) were warranted. Therefore, PDS-Total 
scores were not included as a covariant in subsequent analyses.  
  
ANOVAs were calculated to explore the effects of completion status on continuous study 
variables. While results of these analyses are statistically informative, clinical significance of 
several study measures (i.e., PAI, PICTS, and GAMA) require interpretation based on pre-
determined cut-offs. For example, differences between PAI T-scores of 65 and 72 may not be 
significant via ANOVA, but the analysis of clinically elevated versus not elevated via Pearson’s 
Chi-square analyses may allow for greater clinical utility of results. Therefore, PAI scores were 
recoded to reflect the T≥70 clinical cut-off, PICTS scores were recoded to reflect the T≥60 cut-
off, and GAMA scores were recoded to reflect the IQ = 90 floor of the Average IQ range. 
 
 Recoding sociodemographic data to allow for Pearson’s Chi-square analyses also served 
two purposes. First, recoding categories of the raw data utilizing a median split was necessary in 
order to accurately address current hypotheses. This method of recoding data also replicates data 
coding utilized in similar studies reviewed. Therefore, recoding data via median split aids with 
ease of result interpretation and utility of findings. The following sociodemographic variables 
were recoded as indicated by median split: age, education, number of incarcerations, current 
sentence, and total time served.  A median split was attempted when recoding length of drug use; 
however, only alcohol use (fourteen years), cannabis use (ten years), and cocaine (1 year), had 
median split values above zero. Therefore, to maintain consistency of recoding within the 
category of length of drug use, recoding reflected drug use lasting less than one year and one 
year or more of use (see Table 3).  
 
Second, as a result of the wide variance of participants per cell, recoding of data was 
necessary to facilitate valid analyses (e.g., Chi-square requires N > 5 per cell). To accomplish 
this goal, categorical levels of several sociodemographic factors were collapsed to achieve 
appropriate cell counts (see Table 3). The ethnic groups of Hispanic-American, Asian-American, 
Native-American, and Other were collapsed into a collective “Other” category. The current-
offense categories of Property, Supervised Release Violation, and Other were collapsed into a 
collected “Other” category. The marital-status categories of Divorced and Separated were 
collapsed to form a “Divorce/Separated” category.  
 
To decrease the chance of Type II errors in more complex and empirically informative 
analyses, a less-restrictive significance level was assigned to Pearson’s Chi-square analyses in 
the current study. Therefore, statistically significant variables (p < .05), as well as statistical 
trends at p < .075, as identified by Pearson’s Chi-square analyses were retained for multivariate 
analyses. 
 
Multivariate Analyses 
 
In an effort to help reduce Type I error, cross validation of multivariate analyses were 
attempted. The total sample was divided into a randomly selected testing sample (n = 199) and a 
randomly selected cross-validation sample (n = 55).  
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Logistic Regression. A logistic regression analysis is employed when prediction of a 
dependent dichotomous variable is the research goal. Therefore, to test the aforementioned 
hypotheses, the probability of the occurrence of a treatment-completion status (i.e., complete 
versus non-complete) was examined via a logistic regression analysis performed on the testing 
sample. Significant predictor variables, as identified by preliminary Pearson’s Chi-square 
analyses, were entered into a logistic regression. The resultant statistical model served to identify 
significant independent variables. No definitive guidelines are available with regard to a required 
sample size to independent variables ratio. However, general guidelines ranging from 5:1 to 20:1 
are widely accepted. Therefore, it is believed that statistical power was not jeopardized in the 
current study (e.g., Nielsen and Scarpitti, 2002). 
 
The resultant statistical model was then cross validated on the randomly selected cross-
validation sample. Specifically, the original model was applied to the cross-validation sample of 
inmates to re-examine the predictive ability of the model.  
 
 Discriminant Function Analysis. Significant predictor variables identified by the logistic 
regression were then included in a discriminant function analysis performed on the testing 
sample. The primary objective of the discriminant function analyses (DFA) is to identify a set of 
variables that successfully predict group membership (i.e., completion status). For the purposes 
of the current study, conducting a DFA in addition to logistic regression allowed for a 
determination of the percentage of individuals who were correctly classified as completers or 
non-completers, beyond the probability of chance. (e.g., White et al., 1998). 
 
 The resultant significant predictor variables of the DFA were then cross-validated on the 
same randomly selected cross-validation sample utilized in the logistic regression replication 
process previously described.  Replication of correct classification will serve to further validate 
the predictive power of the significant predictor variables. 
 
Results 
 
Intercorrelations 
 
 Intercorrelations among all study variables were examined. Variables with obvious 
construct similarities (e.g., drug/alcohol use variables) did not reveal significant correlations, as 
illustrated in Table 4. As such, a decision was made not to exclude or collapse any of these 
variables. 
 
Analyses of Sociodemographic Variables 
 
ANOVA results for continuous sociodemographic variables are summarized in Table 5.  
ANOVAs were conducted for each of the continuous predictor variables to explore general 
differences between completers and non-completers. Hypothesized relationships between 
completion status and age, IQ, and education were not supported by ANOVAs. Exploratory 
ANOVAs conducted on the remainder of study variables revealed two significant variables: a 
significant effect of length of current sentence on completion status was found (F(1,252) = 10.048, 
p < .05), and, also, total time served was found to significantly effect completion status (F(1,252) = 
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3.543, p < .05).  
 
Next, Pearson’s Chi-square analyses of sociodemographic variables were conducted.  
Results are summarized in Table 3. As hypothesized, a trend was found between completion 
status and number of incarcerations (χ2  = 4.410, df = 1, p < .075). Within the group of 
completers, the majority (75%) had a history of two incarcerations or fewer, whereas the 
minority (25%) had more incarcerations. No relationship was found between completion status 
and history of violent offenses. Exploratory analyses, however, revealed a significant 
relationship between completion status and length of current sentence (χ2  = 11.578, df = 1, p < 
.001). Within the group of non-completers, the majority (65.9%) have a current sentence 49 
months or fewer. Non-completers had trends toward being more likely to have one year or more 
of alcohol abuse (80.5%) (χ2  = 3.585, df = 1, p < .075) and less than one year of amphetamine 
abuse (79.3%) (χ2  = 3.574, df = 1, p < .075). Completers were more likely to have one year or 
more of cannabis abuse (90.1%) (χ2  = 4.554, df = 1, p < .05).   
 
Analyses of Validity Scales 
 
Validity scale scores for the PAI are summarized in Table 5. Fifty-seven (22.4%) of the 
PAI profiles for the total sample were found to be clinically invalid based on elevations (T ≥ 70) 
on any of the four PAI validity scales. No significant effects on completion status were found for 
each of the PAI validity scales (i.e., Inconsistency, Infrequency, Negative Impression 
Management, and Positive Impression Management) when explored by ANOVAs (Table 6).  
Pearson’s Chi-square analyses were conducted to explore the effects of clinically elevated PAI 
validity scales (i.e., T ≥ 70 and T < 70). Because there were fewer than five completers with 
clinically elevated Inconsistency scores and fewer than five completers and non-completers with 
clinically elevated Positive Impression Management scores, Chi-square analyses could not be 
computed for these scales. Pearson’s Chi-square analyses for the Infrequency and Negative 
Impression Management were not significant (Table 7). In sum, no significant relationship 
between completion status and PAI validity scales were found. Further, from a practical 
perspective, invalid profiles are common among inmate populations. Therefore, it was decided to 
retain these profiles in further analyses and empirically evaluate the practical utility of 
individually elevated clinical, treatment, and interpersonal scales.  
 
Validity scale scores for the PICTS are summarized in Table 5. Sixty-eight (26.8%) of 
the PICTS profiles for this sample were found to be clinically invalid. No significant effects on 
completion status were found for each of the PICTS validity scales (i.e., Confusion-Revised and 
Defensiveness-Revised) when explored by ANOVAs (Table 6). Pearson’s Chi-square analyses 
conducted to examine the effects of clinically elevated and not-elevated PICTS validity scales 
(i.e., T ≥ 60 and T < 60). Because there were fewer than five completers and non-completers 
with clinically elevated Defensiveness-Revised scores, Pearson’s Chi-square analyses could not 
be computed for this scale. Pearson’s Chi-square analysis for Confusion-Revised scale was non-
significant (Table 7). From a practical perspective, invalid profiles are common among inmate 
populations, and thus invalid profiles will be included in the further analyses. 
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Analyses of PAI Clinical and Treatment Scales 
 
Hypothesized relationships between completion status and depressed mood, antisocial 
characteristics, and schizotypal symptoms were not supported. Exploratory ANOVAs were 
conducted on remaining PAI clinical, treatment, and interpersonal scales. Results are 
summarized in Table 8. A significant effect on completion status by Drug Problem (PAI-DRG) 
scores was found (F(1,252) = 6.363, p < .05).  
 
Again, hypothesized effects of clinically elevated and not elevated (i.e., T ≥ 70 and T < 
70) Depression, Antisocial, or Schizotypal scores (i.e., T ≥ 70) were not supported by Pearson’s 
Chi-square analyses (Table 9). Exploratory Pearson’s Chi-square analyses, however, revealed the 
majority of completers (83.7%) had clinically elevated PAI-DRG scores (χ2  = 9.071, df = 1, p < 
.05).  Pearson’s Chi-square analyses could not be computed for the Suicidal Ideation, 
Nonsupport, and Treatment Rejection scales because at least one cell contained fewer than five 
subjects (Table 9).  
 
Analyses of PICTS Scales 
 
 Hypothesized effects on completion status by Mollification, Entitlement, and 
Superoptimism scales were not supported by ANOVA results. Further, completion status was not 
found to be significantly related to any of the remaining PICTS scales. ANOVA results are 
summarized in Table 10.   
 
 Pearson’s Chi-square analyses of clinically elevated and not elevated (i.e., T ≥ 60 and T < 
60) Mollification, entitlement, and superoptimism scales were non-significant (Table 11). 
Exploratory Pearson’s Chi-square analyses revealed the majority of completers (70.9%) had 
clinically elevated Historical (PICTS-HIS) scores (χ2  = 4.622, df = 1, p < .05).   
 
Logistic Regression 
 
 Using significant variables identified by Pearson’s Chi-square analyses (i.e., number of 
incarcerations, length of current sentence, length of alcohol use, length of amphetamine use, 
length of cannabis use, PAI-DRG, and PICTS-HIS) as predictor variables, a logistic regression 
analyses was performed with completion of RDAP as the dependant variable. A total of 199 
cases (excluding the n = 55 cross-validation sample) were analyzed and the full model was 
significantly reliable (χ2  = 29.895, df = 7, p < .0001). This model accounted for 13.9% and 
19.7%  of the variance in completion status, as indicated by the Cox & Snell R Square and 
Nagelkerke R Square, respectively. An impressive 89.9% of completers were successfully 
predicted, but only 32.9% of predictions for non-completers were accurately predicted. Overall, 
72.4% of predictions formed by this model were accurate. Two of the seven predictor variables 
entered into this Logistic Regression were retained as significant predictors of treatment 
completion status (Table 12). To estimate the increase in odds of membership in the target group 
(completers) for each level of the predictor variable, while controlling for other predictors in the 
model, odds ratios for each significant predictor variable were examined. Odds ratios for current 
sentence revealed a current sentence greater than 49 months is associated with an increase in the 
odds of completion by a factor of 2.26 and clinically elevated PAI-DRG scores were associated 
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with an increase in the odds of completion by a factor of 2.59.  Overall, the predictive model 
including these two variables yielded a percentage accuracy in classification (PAC) of 72.4%.  
Sensitivity of this model was 89.9%, with a lower specificity 32.8%.  The positive predictive 
value was 75.2%, with a lower negative predictive value of 58.8% (Table 13).   
 
 These two significant predictor variables were then entered to form a reduced logistic 
regression analyses (Table 12). Examination of the cross-validation sample (n = 55) with the 
reduced model was not found to be statistically reliable (χ2  = 2.772, df = 2, p = .256).   
 
 
Discriminant Function Analysis 
 
 Data from the 199-case testing sample was analyzed in a single discriminant function 
analysis, maintaining the 55-case cross-validation sample for attempted replication of the 
resultant model. A discriminant analysis was performed with completion of RDAP as the 
dependent variable and the significant predictor variables identified in the initial logistic 
regression analysis (i.e., length of current sentence and PAI-DRG) as predictor variables. Prior 
probabilities for group membership, based on the number of cases that fall into each completion 
category instead of standard probability of chance (50%), were 30.7% for non-completers and 
69.3% for completers. The value of this function was significantly different for completers and 
non-completers (χ2  = 19.120, df = 2, p < .0001). The pooled within-group correlations between 
predictor variables and the discriminant function suggested that both variables were good 
predictors of completion status. PAI-DRG was positively correlated with the discriminant 
function value (r = .750), suggesting that participants with clinically elevated PAI-DRG scores 
were more likely to complete RDAP.  Also, length of current sentence was positively correlated 
with the discriminant functioning value (r = .672), suggesting that participants with a current 
sentence longer than 49 months were more likely to complete in RDAP. Overall, the 
discriminant function successfully predicted completion status for 72.4% of cases, with accurate 
predictions being made for 93.5% of completers (Table 14). Unfortunately, 24.59% of non-
completers were accurately predicted, which is 6.1% worse than by chance alone.  
 
 The same discriminant function model was then applied to the 55-case cross-validation 
sample.  Prior probabilities for group membership, based on the number of cases that fall into 
each completion category, were 38.2% for non-completers and 61.8% for completers.  The value 
for this discriminant function analysis was not significant (χ2  = 2.600, df = 2, p = .273). Overall, 
the discriminant function successfully predicted completion status for 70% of cases. Prediction 
of non-completion, however, was wrong 85.7% of the time, 47.5% worse than by chance alone. 
  
Post-Hoc Analyses 
 
 To more carefully understand characteristics of non-completers, additional post-hoc 
analyses were conducted. In the current sample, approximately 20% of the non-completers 
ceased participation after only 125 hours (first quarter of total program), while approximately 
20% of non-completers ceased participation in the final quarter of the total program (completion 
of 375 hours or more). Exploratory ANOVAs revealed significant mean differences on PAI 
Inconsistency scale (F(1,28) = 9.065, p < .01). Significant differences on the following PAI scales 
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were also found: Paranoia (F(1,28) = 6.406, p < .05), Borderline (F(1,28) = 4.324, p < .05), 
Antisocial (F(1,28) = 7.338, p < .05), Suicidal Ideation (F(1,28) = 7.064, p < .05), and Non-Support 
(F(1,28) = 5.525, p < .05). For all significant ANOVAs, early non-completers had higher scale 
means. Pearson’s Chi-square analyses could not be conducted to explore differences between 
elevated and not elevate scale-scores due to the small sub-sample size.  No PICTS-scale mean 
differences were found. 
 
 Given these differences, early non-completers (n = 15) were then compared with a 
sample of completers (n = 30). Based on a 2:1 ratio, completers were matched to non-completers 
based on age and ethnicity.  Exploratory ANOVAs revealed significant mean differences on the 
PAI Inconsistency scale (F(1,44) = 4.962, p < .05), with early non-completers having a higher 
mean score. No other mean differences were found for the remaining PAI scales. On the PICTS, 
the only significant mean difference was found for the Cognitive Indolence scale (F(1,28) = 6.051, 
p < .05), with completers having a higher mean score. Again, due the small sub-sample size, 
Pearson’s Chi-square analyses could not be conducted to explore differences between elevated 
and not-elevated scale scores.  
 
Discussion 
 
Summary of Results 
 
 Significant group differences and trends emerged in the areas of criminal and substance-
abuse histories. Specifically, RDAP completers were more likely to have had a shorter 
incarceration history (i.e., two or fewer) than non-completers, but non-completers were more 
likely to have served shorter sentences (i.e., 49 months or fewer) than completers.  Non-
completers tended to have had alcohol abuse histories lasting at least one year, but shorter 
amphetamine-abuse histories. Completers tended to have cannabis-abuse histories of one year or 
more.  Hypothesized group differences of age, IQ, education, and history of violence were not 
supported by the current data. 
 
 PAI profiles were invalid for 22.4% of completers and non-completers combined. 
Completers and non-completers were equally as likely to present with invalid PAI profiles. 
While not ideal, from a clinical perspective it is not uncommon for inmates in treatment to 
provide dishonest psychological data (Richards & Henry, 2003; McNulty, Forbey, Graham, Ben-
Porath, Black, Anderson, & Burlew, 2003). When self-report is the primary source of 
psychological data, empirical data exploring the clinical utility of invalid data is a resource. 
Further, no significant differences between completers and non-completers were identified when 
examining mean validity-scale scores. Additionally, there were no differences between clinically 
elevated and sub-threshold PAI validity-scale scores. As such, all PAI profiles, valid or invalid, 
were included in data analyses to allow the exploration of possible effects of data to assist in 
discriminating treatment completers from non-completers.   
 
 PAI clinical and treatment scales were first analyzed with scores on a continuum. On this 
level, group differences were found on PAI-DRG, a scale measuring drug use and related social, 
occupational, and recreational difficulties. When PAI scales were recoded to reflect clinical 
elevations (T ≥ 70) and below threshold scores, completers tended to have clinically elevated 
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PAI-DRG scores. PAI-SUI, PAI-NON, and PAI-RXR could not be explored due to an 
insufficient number of completers and non-completers with clinically elevated scores. Finally, 
hypothesized group differences on PAI-DEP, PAI-ANT, and PAI-SCZ were not empirically 
supported. 
 
 Similar to PAI profiles in this study, PICTS profiles were invalid for 26.8% of completers 
and non-completers combined. As previously described, self-report data provided by inmates is 
often invalid (Richards & Henry, 2003; McNulty et al., 2003). Further, no between-group PICTS 
validity-scale differences were shown. As such, all PICTS profiles were included in data 
analyses.   
 No differences on any PICTS scales were found between completers and non-completers. 
When PICTS scores were recoded to reflect clinical elevations (T ≥ 60) and sub-threshold 
scores, more completers were found to have clinically elevated PICTS-HIS scores (i.e., historical 
use of general criminal thinking styles). Criminal thinking styles hypothesized to relate to 
completion status (i.e, Mollification, Entitlement, and Superoptimism) were not found to be more 
common among completers or non-completers. 
 
In sum, seven variables were identified to be significantly related to, or a trend toward, 
program completion status.  Specifically, two criminal-history variables (i.e., number of 
incarcerations and length of current sentence), three drug-use variables (i.e., length of alcohol 
use, amphetamine use, and cannabis use), and one scale from each of the comprehensive 
psychological assessment instruments (i.e., PAI-DRG and PICTS-HIS) were all identified as 
potential predictors of program completion.   
 
To determine the best statistical predictors of program completion, the seven predictor 
variables were analyzed using a logistic regression. Of those, only two variables were retained. 
RDAP participants with current sentences longer than 49 months to complete had 2.26 times 
greater odds of completing RDAP than those who had shorter sentences, and RDAP participants 
with clinically elevated PAI-DRG scores had 2.59 greater odds of completing RDAP than those 
without elevated PAI-DRG scores. Overall, the predictive model including these two variables 
yielded a percentage accuracy in classification (PAC) of 72.4%.  It should be noted, however, 
that a crude prediction of completion status, assuming all RDAP participants will belong to the 
predominant group (completers), yields a PAC of 69.3%. Therefore, overall predictive ability of 
this model should be interpreted cautiously. 
 
This model of predictor variables, as assessed by DFA, produced a hit rate of 72.4%. As 
assessed by logistic regression, this model was able to correctly classify 75.2% (positive 
predictive value) of the completers in this sample. When only looking at completers, 89.9% were 
correctly classified (sensitivity). This suggests good positive predictive ability. The model, 
however, did not have as robust an ability to successfully predict non-completers. Of the entire 
sample, this model was able to correctly classify only 58.8% of non-completers (negative 
predictive value). Further, when solely examining non-completers, only 32.8% were correctly 
classified (specificity). This model is better able to predict program completers than non-
completers.  Unfortunately, results of the logistic regression and discriminant function analyses 
were not replicated on the cross-validation sample, suggesting the need for replication before 
more definitive models of prediction can be certified.   
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Clinical Implications 
 
 In the current study identified predictive factors of program completion (i.e., PAI-DRG 
and longer sentences) are predominantly historical. As such, the cost of misclassifying 
completers or non-completers does not necessarily impact pre-treatment efforts. Rather, results 
of this study (i.e., the model’s propensity to accurately predict completers versus non-
completers) offer a variety of other research and clinical implications.  
 
It is logical that RDAP participants would report histories of drug abuse. While it was 
hypothesized that individuals with specific drug-use histories would be less likely to complete 
RDAP, actual study findings indicate more general drug-use history effects on completion status.  
The PAI-DRG scale measures the severity of an individual’s general drug use history, including 
the negative impact it has had on various social, occupational, and recreational aspects of a 
person’s life.  One reason these individuals may fair better in RDAP is that a large portion of the 
program targets these areas which RDAP completers have independently identified as personally 
relevant. Another reason these individuals may be more likely to complete RDAP is that their 
pre-incarceration lifestyles, including drug use, may have been punishing to the extent that 
potential completers have been motivated to change to avoid future punishing drug-use-related 
consequences. This possibility can be related to previous findings by Pelissier and colleagues 
(2000; 2002; in press) regarding RDAP completers tendency to present in the contemplation or 
maintenance stage of change.  
 
In contrast to previous RDAP studies (Pelissier, 2000; Pelissier, Camp, & Motivans, 
2002; Pelissier, in press), individuals who had longer sentences were more likely to complete 
RDAP in the current study.  Because an individual’s current sentence is not susceptible to 
dishonest responding, as compared to other self-report information (e.g., PAI and PICTS), the 
predictive ability of sentence length may be more reliable. One reason for the predictive ability 
of longer sentences may be similar to that described for elevated PAI-DRG. Specifically, 
completers may have been punished for their criminal behaviors to such a degree that it has 
effectively caused some level a change in their behaviors or cognitions. Completers’ motivation 
for change however, may not be the sole reason for their RDAP success. Pelissier (2000) found 
non-completers tended not to be eligible to benefit from the one-year sentence reduction offered 
upon the successful completion of RDAP. Along the same lines, current findings of the 
predictive power of longer sentences may be related to completers’ motivation to capitalize on 
the sentence-reduction policy. Data necessary to test this theory (i.e., meeting eligibility criteria) 
was not collected in the current study to limit the already expansive list of variables. 
 
While many variables examined in the current study were found not to be significantly 
predictive of program completion, descriptive data can also be used to guide general treatment 
efforts. First, regardless of completion status, participants tended to have IQs in the average 
range or higher, but also tended to have less than high-school educations. This suggests the need 
for academic and/or vocational training for RDAP participants. Fortunately, participation in 
GED classes is generally mandatory for BOP inmates without a high-school degree, but perhaps 
more extensive educational programming for RDAP participants should be explored.   
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Second, each PAI clinical and treatment scale was elevated by at least one RDAP 
participant in this study. Pre-treatment planning, then, could benefit from results of the PAI, or a 
similar comprehensive psychological inventory. Perhaps closer monitoring of symptoms, or 
participation in additional treatment opportunities (e.g., group therapy) for specific psychological 
areas, could be recommended to targeted RDAP participants. Third, each of the eight PICTS 
criminal thinking style scales were elevated by at least 26.8% of participants. The criminal 
thinking scales of cut-off, superoptimism, and cognitive indolence were elevated by more than 
half of all participants.  This supports the need for the criminal-thinking module of RDAP. Pre-
treatment planning, however, may benefit from PICTS results indicating which criminal thinking 
errors are most predominant for each participant. Such information may help treatment providers 
better assess an individual’s criminal-thinking tendencies and provide more structured cognitive-
modification strategies for these individuals.   
 
Finally, as examined in some non-RDAP treatment retention studies (e.g., McCaul, 
Svikis, & Moore, 2001; Nielson & Scarpetti, 2002), examination of differences between sub-
groups within the total sample was conducted.  In the current sample, approximately 20% of the 
non-completers ceased participation after only 125 hours (first quarter of total program), while 
approximately 20% of non-completers ceased participation in the final quarter of the total 
program (completion of 375 hours or more). Exploratory analyses found early non-completers 
had higher mean scores on the following PAI scales: Inconsistency, Paranoia, Borderline, 
Antisocial, Suicidal Ideation, and Non-Support. This suggests the possibility that Axis II 
characteristics may distinguish early non-completers from late non-completers.  No PICTS mean 
differences emerged. Early non-completers were found have a significantly higher mean validity-
scale score on the PAI (Inconsistency) than the matched sub-sample of completers. Interestingly, 
however, completers were found to have a significantly higher mean score on the PICTS 
Cognitive Indolence scale. These results suggest the possibility that non-completers are not a 
homogeneous group. Further, early non-completers and completers appear to present with 
significantly different characteristics, and thus, comparison of these groups may be warranted. 
Given the high possibility of Type I error on these post-hoc analyses, these results should be 
cautiously interpreted. Additionally, future research could seek to replicate these findings on 
larger samples.  Gaining a better understanding of completers and non-completers may allow for 
a more economical use of therapeutic resources for identified sub-groups of RDAP participants. 
 
Limitations and Future Research 
 
The greatest limitation of the current study is the increased chance of Type I error. 
Because most hypotheses were not supported, exploratory analyses were conducted, totaling 60 
variables examined. As a result, the number of statistical analyses actually conducted was greater 
than those planned. Planned cross-validation analyses as components of the logistic regression 
and discriminant function analysis were included in the current study to help control Type I 
error.  Unfortunately, logistic regression and discriminant function analysis cross validations 
were unsuccessful. As a result, Type I error remains a significant concern. While the current 
sample was relatively large, cross validation of the current findings on a larger sample is 
recommended. 
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 Another sampling concern is the high percentage of technically invalid PAI and PICTS 
profiles.  As previously discussed, invalid self-report data is not uncommon among inmate 
populations (Richards & Pai, 2003; McNulty et al., 2003) and there was no statistical difference 
between completers and non-completers in the current study. Therefore, a decision was made to 
include these cases in the current study for the sake of clinical utility. Empirically, however, 
analyses may have yielded different results had only valid profiles been included.1 This would 
have allowed for analyses of the predictive ability of true symptoms, rather than self-reported 
psychological symptoms and maladaptive cognitions which were likely distorted to some degree.  
 
 While the focus of the current study was to provide a clinically useful checklist of 
symptoms which may help predict RDAP completion, examining data on a categorical basis, 
rather than on a continuum may have resulted in a less sensitive approach to the data. For 
example, due to cell-count requirements for Pearson’s Chi-square analyses, participants of 
several ethnic groups were crudely combined to form an “Other” category. Future research may 
consider limiting analyses to sufficiently large sub-samples of ethnic groups. 
 
RDAP participants’ interactions with children should also be considered. Interestingly, in 
the current sample, 74.8% reported having at least two children. Often times these fathers do not 
have regular contact with their children and have served as poor role models for children with 
whom they do have contact. Further examination of the parent/child dynamic of RDAP 
participants is recommended to help guide future parent training programs for this population. 
 
 This is the first study to examine the PICTS ability to predict RDAP completion. Results 
of the current study suggest no significant predictive ability of this measure. Since the criminal 
thinking errors measured by the PICTS comprise a significant module of RDAP, better 
understanding of the utility of this measure is warranted. At present, additional research is 
needed to broaden empirical understanding of the predictive ability of the PICTS. For example, 
studies including inmates from different security levels, or female inmates, may yield different 
results. Similarly, RDAP participants at FCI Morgantown are a fairly homogeneous group (e.g., 
male, low security level, predominantly non-violent and incarcerated for drug related offenses); 
therefore, replication of all aspects of the current study should be conducted on various RDAP 
samples. 
 
Given the differences of the current results as compared to previous RDAP related 
research, further exploration of predictive factors of RDAP completion are warranted. For 
example, while predictive factors may be related to participants’ personal stage of change, 
formal assessment of participants’ preparedness for personal change utilized in previous RDAP 
studies (Pelissier, 2000; Pelissier, Camp, & Motivans, 2002; Pelissier, in press), were not 
included in the current study. RDAP participants’ eligibility to benefit from the one-year 
sentence-reduction policy following RDAP completion, assessed by Pelissier and colleagues, 
was also beyond the scope of the current study. Examination of this factor with a low-security 
sample should be considered for future research.  
 
Finally, exploring other areas in the prediction of RDAP completion is warranted.  For 
example, perhaps drug treatment specialists’ (DTS) level of training may affect a RDAP 
treatment group’s completion rate. The ethnicity of a DTS may also be examined for possible 
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inter-ethnic differences in RDAP participants’ completion status (e.g., Kang et al., 1991). 
Similarly, perhaps DTS gender may affect participants’ completion status. Another area to 
explore may also be inter-cohort factors; perhaps dynamics within the cohort affect an 
individual’s progress and eventual completion status. While the current study expanded upon 
previous findings, it is evident that more empirical understanding of this area is needed. 
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Appendix A 
Personality Assessment Inventory (PAI; Morey, 1991) 
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Appendix B 
Paulhus Deception Scales (PDS; Paulhus, 1998) 
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Appendix C 
Psychological Inventory of Criminal Thinking Styles (Walters, 1991) 
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Footnotes 
 
1 For exploratory purposes, analyses were conducted on valid-only PAI profiles. ANOVAs 
conducted on valid-only PAI profiles did not yield any significant mean differences.  Pearson’s 
Chi-square analyses on valid PAI profiles produced similar results to the analyses on the total 
sample, showing the majority of completers (86.4%) had clinically elevated Drug Problem scores 
(χ2  = 9.287, df = 1, p < .01).  For exploratory purposes, analyses were also conducted on valid-
only PICTS profiles. ANOVAs conducted on valid-only PICTS profiles did not yield any 
significant mean differences. Pearson’s Chi-square analyses on valid PICTS profiles produced 
two significant results. The majority of non-completers (78.9%) did not have elevated 
Mollification scale scores (χ2  = 5.142, df = 1, p < .05) and 71.9% did not have elevated 
Cognitive Indolence scale scores (χ2  = 5.127, df = 1, p < .05).   
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Table 1  
Assessment Measures Utilized 
 
Measure 
 
Scoring 
 
Format 
 
Reading Level 
 
Time to Administer 
 
GAMA 
 
M = 100  
 
(SD=15) 
 
Stimulus Booklet 
 
Multiple-choice 
 
 
2.5 grade 
 
25 min. (timed) 
 
PAI  
 
T ≥ 70 interpreted 
 
Self-Report 
 
Likert-type 
 
 
4th grade 
 
Approx. 45 min. 
 
PDS 
 
Higher scores = dishonest responding 
 
Self-Report 
 
Likert-type 
 
 
5th grade 
 
Approx. 10 min. 
 
PICTS 
 
T ≥ 60 interpreted 
 
Self-Report 
 
Likert-type 
 
 
6th grade 
 
15-30 min. 
Note. GAMA = General Abilities Measure for Adults, PAI = Personality Assessment Inventory, PDS = Paulhus Deception Scale, 
PICTS = Psychological Inventory of Criminal Thinking Styles.  
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Table 2 
 
Demographic Data for Total Sample 
 
  
Mean 
 
SD 
 
N 
 
Percentage 
 
Age 
 
 
36.15 
 
9.87 
  
Education 
 
12.09 2.13   
GAMA 
 
97.44 12.57   
Current Sentence (months) 
 
60.96 37.69   
Total Time Served (months) 
 
36.61 35.09   
Number of Incarcerations 
 
2.33 2.66   
Number of Children 
 
1.95 1.80   
Voluntary Outpatient 
 
.59 1.67   
Involuntary Outpatient 
 
.45 1.77   
Voluntary Inpatient 
 
.33 1.01   
Involuntary Inpatient 
 
.26 1.93   
Alcohol Use (years) 
 
15.94 10.06   
Amphetamine Use (years) 
 
2.28 4.88   
Cannabis Use (years) 12.42 
 
9.77   
Cocaine Use (years) 
 
5.32 7.56   
Hallucinogen Use (years) 
 
1.19 3.82   
Inhalant Use (years) 
 
.22 1.81   
Opiate Use (years) 
 
1.43 4.12   
PCP Use (years) 
 
.46 1.88   
Sedative/Hypnotics/Anxiolytic Use (years) 1.36 4.15 
 
  
Other Drug Use (years) .44 1.62 
 
  
            Treatment Completion   38 
 
 
 
 
Mean 
 
SD 
 
N 
 
Percentage 
Ethnicity 
 
    
     Caucasian 
 
  88 34.6% 
     African-American 
 
  137 53.9% 
     Hispanic-American 
 
  19 7.5% 
     Asian-American 
 
  4 1.6% 
     Native-American 
 
  4 1.6% 
     Other 
 
  2 .8% 
Marital Status 
 
    
     Single 
 
  130 51.2% 
     Married/Common-Law 
 
  78 30.7% 
     Separated 
 
  9 3.5% 
     Divorced 
 
  37 14.6% 
Current Offense 
 
    
     Drug 
 
  226 89% 
     Property 
 
  3 1.2% 
     Violation 
 
  1 .4% 
     Other 
 
  24 9.4% 
History of Violence 
 
    
     Yes 
 
  228 89.8% 
     No 
 
  26 10.2% 
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Table 3 
 
Sociodemographic Variables by Completion Status 
 
 
          Sociodemographics 
 
 
Non-completers 
 
n = 82 
 
Completers 
 
n = 172 
 
χ 2
 
Age 
 
   
1.153 
     35 and younger 
 
45 (54.9%) 82 (47.7%)  
     Older than 35 
 
37 (45.1%) 90 (52.3%)  
Education 
 
  .000 
 
     Less than 12 yrs 
 
61 (74.4%) 128 (74.4%)  
     12 yrs/GED or more 
 
21 (25.6%) 44 (25.6%)  
GAMA 
 
  1.611 
     < 90 
 
16 (19.5%) 23 (13.4%)  
     ≥ 90 
 
66 (80.5%) 149 (84.6%)  
Marital Status       
 
  .299 
     Married/Common-law 
 
24 (29.3%) 54 (31.4%)  
     Separated a 
 
3 (3.7%) 6 (3.5%)  
     Divorced a 
 
11 (13.4%) 26 (15.1%)  
     Single 
 
44 (53.7%) 86 (50%)  
Number of Children 
 
  .264 
     2 or less 
 
19 (23.2%) 45 (26.2%)  
     More than 2 63 (24.8%) 127 (73.8%)  
 
 
 
 
 Treatment Completion   40 
 
 
          Sociodemographics 
 
 
Non-completers 
 
n = 82 
 
Completers 
 
n = 172 
 
χ 2
 
Ethnicity 
 
   
1.555 
     Caucasian 
 
24 (29.3%) 63 (36.6%)  
     African-American b
 
49 (59.8%) 89 (51.7%)  
     Hispanic-American b
 
7 (8.5%) 12 (7.0%)  
     Asian-American b
 
2 (2.4%) 2 (1.2%)  
     Native-American b
 
0 (0%) 4 (2.3%)  
     Other b
 
0 (0%) 2 (1.2%)  
History of Violent Offenses 
 
  1.123 
     No 
 
76 (92.7%) 152 (88.4%)  
     Yes 
 
6 (7.3%) 20 (11.6%)  
Number of Incarcerations 
 
  4.410*
     2 incarcerations or less 
 
51 (62.2%) 129 (75%)  
     More than 2 incarcerations 
 
31 (37.8%) 43 (25%)  
Length of Current Sentence 
 
  11.578***
     49 months or less 
 
54 (65.9%) 74 (43%)  
     More than 49 months 
 
28 (34.1%) 98 (57%)  
Total Time Served 
 
   
2.093 
     25 months or less 
 
48 (58.5%) 84 (48.8%)  
     More than 25 months 34 (41.5%) 88 (51.2%)  
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          Sociodemographics 
 
 
Non-completers 
 
n = 82 
 
Completers 
 
n = 172 
 
χ 2
 
Current Offense 
 
   
1.609 
     Drug 
 
70 (85.4%) 156 (90.7%)  
     Property c
 
0 (0%) 3 (1.7%)  
     Supervised Release Violation c
 
0 (0%) 1 (.6%)  
     Other c
 
12 (14.6%) 12 (7%)  
Substance Abuse Treatment History 
 
  .529 
     No 
 
29 (35.4%) 69 (40.1%)  
     Yes 
 
53 (64.6%) 103 (59.9%)  
Alcohol Use  
 
  3.585*
     Less than 1 year 
 
66 (80.5%) 119 (69.2%)  
     1 year or more 
 
16 (19.5%) 53 (30.8%)  
Amphetamine Use 
 
  3.547*
     Less than 1 year 
 
65 (79.3%) 117 (68%)  
     1 year or more 
 
17 (20.7%) 55 (32%)  
Cannabis Use 
 
  4.554**
     Less than 1 year 
 
16 (19.5%) 17 (9.9%)  
     1 year or more 
 
66 (80.5%) 155 (90.1%)  
Cocaine Use 
 
  .181 
     Less than 1 year 
 
40 (48.8%) 79 (45.9%)  
     1 year or more 
 
42 (51.2%) 93 (54.1%)  
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          Sociodemographics 
 
 
Non-completers 
 
n = 82 
 
Completers 
 
n = 172 
 
χ 2
Hallucinogens 
 
  .221 
     Less than 1 year 
 
66 (80.5%) 134 (77.9%)  
     1 year or more 
 
16 (19.5%) 38 (22.1%)  
Inhalants 
 
  .213 
     Less than 1 year 
 
76 (92.7%) 162 (94.2%)  
     1 year or more 
 
6 (7.3%) 10 (5.8%)  
Opiates 
 
  1.347 
     Less than 1 year 
 
69 (84.1%) 134 (77.9%)  
     1 year or more 
 
13 (15.9%) 38 (22.1%)  
Phencyclidine 
 
  .030 
     Less than 1 year 
 
74 (90.2%) 154 (89.5%)  
     1 year or more 
 
8 (9.8%) 18 (10.5%)  
Sedatives/Hypnotics/Anxiolytics 
 
  .008 
     Less than 1 year 
 
63 (76.8%) 133 (77.3%)  
     1 year or more 
 
19 (23.2%) 39 (22.7%)  
Other Substances 
 
  .506 
     Less than 1 year 
 
72 (87.8%) 156 (90.7%)  
     1 year or more 10 (12.2%) 16 (9.3%)  
Note. a Collapsed into a “Divorced/Separated” category for purposes of Chi-square calculations 
due to N ≥ 5 per cell. b Collapsed into “Other” category for purposes of Chi-square calculation 
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due to N ≥ 5 per cell. c Collapsed into an “Other” category for purposes of Chi-square calculation 
due to N ≥ 5 per cell.  GAMA = General Abilities Measure for Adults. 
* p < .075. **p < .05. ***p < .001. 
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Table 4 
 
Correlations among related variables 
            2 3 4 5 6 7 8 9 10 11 12
 
1) PAI-DRG 
 
 
.148* 
 
.318**
 
.041 
 
.091 
 
.114 
 
.153* 
 
.136* 
 
.179**
 
-.065 
 
 .124* 
 
.071 
 
2) PAI-ALC 
 
 
.318** .041        .083 .222** .114 .100 .080 .085 .183* .100
 
3) Alcohol  
         .148* .436* .386* .214** .087 .082 .013 .249** .059
 
4) Amphetamine 
    .103 -.108 .143* .123* -.016 .074 .230* -.060
 
5) Cannabis 
     .384** .239* .081 -.035 .136* .264** -.086
 
6) Cocaine 
      .266** .147* .171* .088 .200* -.055
 
7) Hallucinogens 
       .456** .181* .177** .221** .111
 
8) Inhalants 
        .025 .364** .271** .014
 
9) Opiates 
          -.042 .071 .058
 
10) PCP 
          .064 .003
 
11) Sedatives 
           .090
 
12) Other drugs 
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Table 5  
 
ANOVA results for Sociodemographic Data 
 
Sociodemographics 
 
 
Non-completers 
 
N = 82 
 
Completers 
 
N = 172 
 
F (1,252) 
 
Partial 
 
Eta2
 
Age 
 
 
35.43  
 
(10.80) 
 
 
36.49  
 
(9.40) 
 
.649 
 
.003 
Years of Education 
 
11.78  
 
(2.29) 
 
12.23  
 
(2.03) 
2.529 .010 
GAMA 
 
95.72 
 
(13.66) 
98.27 
 
(11.96) 
 
2.295 .009 
Number of Children 
 
1.77 
 
 (1.73) 
 
2.03  
 
(1.92) 
1.224 .005 
Number of Incarcerations 
 
2.44  
 
(1.90) 
 
2.28 
 
 (2.97) 
.185 .001 
Length of Current Sentence 
months 
 
50.29 
 
 (31.16) 
 
66.05  
 
(39.51) 
10.048** .038 
Total Time Served (months) 
 
30.63  
 
(29.68) 
 
39.45  
 
(37.14) 
3.543* .014 
Number of Drug Treatment Pgms 
 
    
     Voluntary Outpatient 
 
.74  
 
(1.73) 
 
.52 
 
 (1.64) 
1.024 .004 
     Voluntary Inpatient 
 
.32  
 
(.84) 
 
.33  
 
(1.08) 
.011 .000 
 
 
 Treatment Completion   46 
 
 
Sociodemographics 
 
 
Non-completers 
 
N = 82 
 
Completers 
 
N = 172 
 
F (1,252) 
 
Partial 
 
Eta2
 
     Involuntary Outpatient 
 
 
.45  
 
(1.43) 
 
 
.45  
 
(1.91) 
 
.000 
 
.000 
     Involuntary Inpatient 
 
.15 
 
 (.42) 
 
.31  
 
(2.33) 
.417 .002 
Alcohol Use (years) 
 
15.44  
 
(11.18) 
 
16.18 
 
 (10.43) 
.270 .001 
Amphetamine Use (years) 
 
1.32  
 
(3.62) 
 
2.74  
 
(5.33) 
4.763** .019 
Cannabis Use (years) 
 
11.57 
 
 (9.44) 
 
12.82 
 
 (9.94) 
.902 .004 
Cocaine Use (years) 
 
5.13 
 
 (7.00) 
 
5.40  
 
(7.83) 
.071 .000 
Hallucinogen Use (years) 
 
1.41 
 
 (4.18) 
 
1.08  
 
(3.64) 
.430 .002 
Inhalant Use (years) 
 
.46 
 
 (3.05) 
 
.10 
 
 (.61) 
2.238 .009 
Opiate Use (years) 
 
1.30  
 
(3.87) 
 
1.48  
 
(4.25) 
.103 .749 
 
 
 Treatment Completion   47 
 
 
**p < .05. 
 
Sociodemographics 
 
 
Non-completers 
 
N = 82 
 
Completers 
 
N = 172 
 
F (1,252) 
 
Partial 
 
Eta2
 
Phencyclidine Use (years) 
 
 
.50  
 
(1.80) 
 
 
.44  
 
(1.92) 
 
.058 
 
.000 
Sedatives/Hypnotics/Anxiolytics 
(years 
 
1.39  
 
(3.30) 
 
1.34  
 
(4.51) 
.007 .000 
Other Drug Use (years) 
 
.34 
 
 (1.18) 
.48 
 
 (1.79) 
.430 .002 
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Table 6 
 
ANOVA results for all Validity Scales 
 
Scale 
 
Non-Completers 
 
Completers 
 
F(1,252) 
 
Partial Eta2
 
PDS-Total 
 
 
8.76 
 
(5.79) 
 
 
7.90 
 
(4.57) 
 
1.649 
 
.007 
PAI  INC 53.79
 
(8.42) 
52.42 
 
(7.46) 
 
1.730 .007 
PAI  INF 55.27 
 
(9.18) 
55.02 
 
(9.16) 
 
.040 .000 
PAI NIM 55.76 
 
(10.52) 
55.97 
 
(12.05) 
 
.018 .000 
PAI PIM 43.99 
 
(10.73) 
42.21 
 
(10.66) 
 
1.539 .006 
PICTS Cf-r 
 
55.49 
 
(10.41) 
 
54.85 
 
(9.89) 
 
.384 .002 
PICTS Df-r 40.87 
 
(10.33) 
39.34 
 
(8.73) 
1.498 .006 
 
Note. PDS-Total = Paulhus Deception Scale – Total score; PAI = Personality Assessment 
Inventory; INC = Inconsistency; INF = Infrequency; NIM = Negative Impression Management; 
PIM = Positive Impression Management. PICTS = Psychological Inventory of Criminal 
Thinking Styles; Cf-r = Confusion-Revised; Df-r = Defensiveness-Revised; Discrepancies in N 
reflect lack of data for all participants. Results not significant at p < .05. 
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Table 7 
 
Clinically Elevated Validity Scale Chi-Square Analyses 
 
Scale 
 
Non-Completers 
 
Completers 
 
χ 2 
 
PAI  INC 
 
   
--- 
     < 70 
 
77 (93.9%) 168 (97.7%)  
     ≥ 70 
 
5 (6.1%) 4 (2.3%)  
PAI  INF 
 
  .180 
     < 70 
 
77 (93.9%) 159 (92.4%)  
     ≥ 70 
 
5 (6.1%) 13 (7.6%)  
PAI NIM 
 
  .256 
     < 70 
 
72 (87.8%) 147 (85.5%)  
     ≥ 70 
 
10 (12.2%) 25 (14.5%)  
PAI PIM 
 
  --- 
     < 70 
 
82 (100%) 171 (99.4%)  
     ≥ 70 
 
0 (0%) 
 
1 (.6%)  
PICTS Cf-r 
 
  .384 
     < 70 
 
60 (73.2%) 132 (76.7%)  
     ≥ 70 
 
22 (26.8%) 40 (23.3%)  
PICTS Df-r 
 
  --- 
     < 70 
 
79 (96.3%) 169 (98.3%)  
     ≥ 70 
 
3 (3.7%) 3 (1.7%)  
 
Note. PAI = Personality Assessment Inventory; INC = Inconsistency; INF = Infrequency; NIM = 
 
 
 Treatment Completion   50 
Negative Impression Management; PIM = Positive Impression Management. PICTS = 
Psychological Inventory of Criminal Thinking Styles; Cf-r = Confusion-Revised; Df-r = 
Defensiveness-Revised. Results not significant at p < .075. 
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Table 8 
 
PAI Clinical, Treatment, and Interpersonal Subscale Main Effects 
 
 
PAI 
 
Scales 
 
 Non-Completers 
 
 
 
Completers 
 
 
 
F(1,252) 
 
Partial Eta2 
 
SOM 
 
 
54.37 
 
(11.78) 
 
53.56 
 
(10.30) 
 
 
.578 
 
.001 
ANX 55.66 
 
(9.45) 
56.05 
 
(10.60) 
 
.082 .000 
ARD 
 
59.65 
 
(9.50) 
 
58.32 
 
(10.46) 
.947 .004 
DEP 55.90 
 
(8.60) 
 
55.63 
 
(9.17) 
.052 .000 
MAN 55.89 
 
(11.49) 
 
53.76 
 
(10.62) 
2.115 .008 
PAR 61.39 
 
(11.88) 
 
62.08 
 
(10.22) 
.228 .001 
SCZ 56.51 
 
(11.20) 
 
56.77 
 
(10.85) 
.030 .000 
BORD 63.45 
 
(9.77) 
 
63.69 
 
(10.35) 
.038 .000 
ANT 65.82 
 
(11.88) 
65.98 
 
(11.35) 
.011 .000 
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PAI 
 
Scales 
 
 Non-Completers 
 
 
 
Completers 
 
 
 
F(1,252) 
 
Partial Eta2 
 
ALC 
 
68.89 
 
(16.49) 
 
 
72.38 
 
(16.87) 
 
2.408 
 
.122 
DRG 78.83 
 
(16.07) 
 
84.31 
 
(16.23) 
6.363** .025 
AGG 56.98 
 
(12.04) 
 
56.60 
 
(11.84) 
.054 .000 
SUI 49.07 
 
(7.38) 
 
48.40 
 
(7.90) 
.419 .002 
STR 60.17 
 
(11.22) 
 
61.05 
 
(10.66) 
.362 .001 
NON 53.94 
 
(10.15) 
 
56.60 
 
(10.15) 
3.811 .015 
RXR 34.77 
 
(8.24) 
34.56 
 
(8.46) 
.035 .000 
Note. PAI = Personality Assessment Inventory; SOM = Somatic Complaints ANX = Anxiety; 
ARD = Anxiety Related Disorders; DEP = Depression; MAN = Mania; PAR = Paranoia; SCZ = 
Schizophrenia; BORD = Borderline Features; ANT = Antisocial Features; ALC = Alcohol 
Problems; DRG= Drug Problems; AGG = Aggression; SUI = Suicidal Ideation; STR = Stress; 
NON = Nonsupport; RXR = Treatment Rejection. All reported scores are T-Scores.  
**p < .05. 
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Table 9 
 
PAI Clinical, Treatment, and Interpersonal Subscale Chi-Square Analyses 
 
 
PAI 
 
Scales 
 
Non-Completers 
 
n = 72 
 
Completers 
 
n = 182 
 
χ 2 
 
SOM 
 
  
 
 
.013 
< 70 
 
74 (90.2%) 156 (90.7%)  
≥ 70 
 
8 (9.8%) 16 (9.3%)  
ANX 
 
  .444 
< 70 
 
76 (92.7%) 155 (90.1%)  
≥ 70 
 
6 (7.3%) 17 (9.9%)  
ARD 
 
  2.380 
< 70 
 
66 (80.5%) 151 (87.8%)  
≥ 70 
 
16 (19.5%) 21 (12.2%)  
DEP 
 
  .354 
< 70 
 
74 (90.2%) 159 (92.4%)  
≥ 70 
 
8 (9.8%) 13 (7.6%)  
MAN   
 
2.549 
< 70 
 
70 (85.4%) 158 (91.9%)  
≥ 70 
 
12 (14.6%) 14 (8.1%)  
PAR   
 
.017 
< 70 
 
64 (78%) 133 (77.3%)  
≥ 70 
 
18 (22%) 39 (22.7%)  
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PAI 
 
Scales 
 
Non-Completers 
 
n = 72 
 
Completers 
 
n = 182 
 
χ 2 
 
SCZ 
 
   
.072 
< 70 
 
72 (87.8%) 153 (89%)  
≥ 70 
 
10 (12.2%) 19 (11%)  
BORD 
 
  .007 
< 70 
 
60 (73.2%) 125 (72.7%)  
≥ 70 
 
22 (26.8%) 47 (27.3%)  
ANT 
 
  2.486 
< 70 
 
48 (58.5%) 118 (68.6%)  
≥ 70 
 
34 (41.5%) 54 (31.4%)  
ALC 
 
  
 
2.041 
< 70 
 
46 (56.1%) 
 
80 (46.5%)  
≥ 70 
 
36 (43.9%) 
 
92 (53.5%)  
DRG  
 
 9.071** 
< 70 
 
27 (32.9%) 
 
28 (16.3%)  
≥ 70 
 
55 (67.1%) 
 
144 (83.7%)  
AGG  
 
 .148 
< 70 
 
72 (87.8%) 
 
148 (86%)  
≥ 70 
 
10 (12.2%) 
 
24 (14%)  
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PAI 
 
Scales 
 
Non-Completers 
 
n = 72 
 
Completers 
 
n = 182 
 
χ 2 
 
SUI 
 
 
 
  
--- 
< 70 
 
81 (98.8%) 
 
165 (95.9%)  
≥ 70 
 
1 (1.2%) 
 
7 (4.1%)  
STR  
 
 .264 
< 70 
 
62 (75.6%) 
 
135 (78.5%)  
≥ 70 
 
20 (24.4%) 
 
37 (21.5%)  
NON  
 
 --- 
< 70 
 
78 (95.1%) 
 
163 (94.8%)  
≥ 70 
 
4 (4.9%) 
 
9 (5.2%)  
RXR  
 
 --- 
< 70 
 
82 (100%) 
 
171 (99.4%)  
≥ 70 
 
0 (0%) 
 
1 (.6%)  
Note. PAI = Personality Assessment Inventory; SOM = Somatic Complaints ANX = Anxiety; 
ARD = Anxiety Related Disorders; DEP = Depression; MAN = Mania; PAR = Paranoia; SCZ = 
Schizophrenia; BORD = Borderline Features; ANT = Antisocial Features; ALC = Alcohol 
Problems; DRG= Drug Problems; AGG = Aggression; SUI = Suicidal Ideation; STR = Stress; 
NON = Nonsupport; RXR = Treatment Rejection.  Chi-square analyses for SUI, NON, and RXR 
could not be calculated due to cell count < 5. 
**p < .05. 
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Table 10 
ANOVA results for PICTS  
 
 
PICTS 
 
Scales 
 
 Non-Completers 
 
 
 
Completers 
 
 
 
F(1,252) 
 
Partial Eta2 
 
Mo 
 
 
55.91 
 
(11.99 
 
57.90 
 
(12.67) 
 
 
1.411 
 
.006 
Co 58.71 
 
(10.17) 
59.35 
 
(9.43) 
 
.244 .001 
En 
 
57.13 
 
(10.81) 
 
56.51 
 
(10.29) 
.200 .001 
Po 57.80 
 
(11.63) 
 
56.28 
 
(11.15) 
1.004 .004 
Sn 52.95 
 
(11.82) 
 
52.87 
 
(9.57) 
.003 .000 
So 62.91 
 
(12.78) 
 
62.16 
 
(11.47) 
.221 .001 
Ci 
 
 
58.24 
 
(9.52) 
 
59.27 
 
(9.42) 
.652 .003 
Ds 57.15 
 
(10.66) 
 
58.35 
 
(9.80) 
.797 .003 
CUR 57.62 
 
(9.71) 
58.51 
 
(9.87) 
.450 .002 
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PICTS 
 
Scales 
 
 Non-Completers 
 
 
 
Completers 
 
 
 
F(1,252) 
 
Partial Eta2 
 
HIS 
 
62.06 
 
(11.43) 
 
 
63.85 
 
(10.41) 
 
1.538 
 
.006 
PRB 
 
58.13 
 
(9.72) 
 
59.34 
 
(9.69) 
.854 .003 
HOS 
 
52.76 
 
(11.02) 
 
52.98 
 
(11.19) 
.023 .000 
AST 
 
61.49 
 
(11.00) 
 
62.08 
 
(10.71) 
.164 .001 
DNH 
 
52.06 
 
(10.21) 
 
50.80 
 
(9.48) 
.931 .004 
FOC 
 
60.13 
 
(10.95) 
61.57 
 
(10.91) 
.959 .004 
 
Note. PICTS = Psychological Inventory of Criminal Thinking Styles; Mo = Mollification; Co = 
Cut-Off; En = Entitlement; Po = Power Orientation; Sn = Sentimentality; So = Superoptimism; 
Ci = Cognitive Indolence; Ds = Discontinuity; CUR = Current; HIS = Historical; PRB = 
Problem Avoidance; HOS = Interpersonal Hostility; AST = Self-Assertion; DNH = Denial of 
Harm; FOC = Fear of Change. All reported scores are T-Scores.   
Results not significant at p < .05. 
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Table 11 
PICTS Chi-Square Analyses 
 
 
PICTS 
 
Scales 
 
Non-Completers 
 
n = 72 
 
Completers 
 
n = 182 
 
χ 2 
 
Mo 
 
  
 
 
2.583 
< 60 
 
54 (65.9%) 95 (55.2%)  
≥ 60 
 
28 (34.1%) 77 (44.5%)  
Co 
 
  1.519 
< 60 
 
43 (52.4%) 76 (44.2%)  
≥ 60 
 
39 (47.6%) 96 (55.8%)  
En 
 
  2.189 
< 60 
 
47 (57.3%) 115 (66.9%)  
≥ 60 
 
35 (42.7%) 57 (33.1%)  
Po 
 
  .557 
< 60 
 
47 (57.3%) 107 (62.2%)  
≥ 60 
 
35 (42.7%) 65 (37.8%)  
Sn   
 
.000 
< 60 
 
60 (73.2%) 126 (73.3%)  
≥ 60 
 
22 (26.8%) 46 (26.7%)  
So   
 
.454 
< 60 
 
38 (46.3%) 72 (41.9%)  
≥ 60 
 
44 (53.7%) 100 (58.1%)  
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PICTS 
 
Scales 
 
Non-Completers 
 
n = 72 
 
Completers 
 
n = 182 
 
χ 2 
 
Ci 
 
   
2.019 
< 60 
 
45 (54.9%) 78 (45.3%)  
≥ 60 
 
37 (45.1%) 94 (54.7%)  
Ds 
 
  .025 
< 60 
 
43 (52.4%) 92 (53.5%)  
≥ 60 
 
39 (47.6%) 80 (46.5%)  
CUR 
 
  .482 
< 60 
 
41 (50%) 94 (54.7%)  
≥ 60 
 
41 (50%) 78 (45.3%)  
HIS 
 
  
 
4.622** 
< 60 
 
35 (42.7%) 
 
50 (29.1%)  
≥ 60 
 
47 (57.3%) 
 
122 (70.9%)  
PRB  
 
 .693 
< 60 
 
47 (57.3%) 
 
89 (51.7%)  
≥ 60 
 
35 (42.7%) 
 
83 (48.3%)  
HOS  
 
 .888 
< 60 
 
65 (79.3%) 
 
127 (73.8%)  
≥ 60 
 
17 (20.7%) 
 
45 (26.2%)  
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PICTS 
 
Scales 
 
Non-Completers 
 
n = 72 
 
Completers 
 
n = 182 
 
χ 2 
 
AST 
 
 
 
  
.007 
< 60 
 
30 (36.6%) 
 
62 (36%)  
≥ 60 
 
52 (63.4%) 
 
110 (64%)  
DNH  
 
 .003 
< 60 
 
67 (81.7%) 
 
141 (82%)  
≥ 60 
 
15 (18.3%) 
 
31 (18%)  
FOC  
 
 .572 
< 60 
 
37 (45.1%) 
 
69 (40.1%)  
≥ 60 45 (54.9%) 103 (59.9%)  
Note. PICTS = Psychological Inventory of Criminal Thinking Styles; Mo = Mollification; Co = 
Cut-Off; En = Entitlement; Po = Power Orientation; Sn = Sentimentality; So = Superoptimism; 
Ci = Cognitive Indolence; Ds = Discontinuity; CUR = Current; HIS = Historical; PRB = 
Problem Avoidance; HOS = Interpersonal Hostility; AST = Self-Assertion; DNH = Denial of 
Harm; FOC = Fear of Change.  
**p < .05. 
 
     Treatment Completion   61 
Table 12 
Logistic Regression Analyses for Prediction of Completers 
  
n = 199 
  
n = 55 
    
Parameter  
 
Estimate 
 
SE 
 
Wald χ 2 
 
Odds  
 
Ratio 
Parameter  
 
Estimate 
 
 
SE 
 
Wald χ 2 
 
Odds  
 
Ratio 
 
Current Sentence 
( ≤ or > 49 months) 
 
.814 
 
.363 
 
5.021** 
 
2.256 
  
.924 
 
.578 
 
2.551 
 
2.519 
# of Incarcerations 
( ≤ or > 2) 
-.642         
         
         
         
.354 3.299 .526
Alcohol Use 
(< or ≥ 1 year)  
-.114 1.844 .004 .892
Amphetamine Use 
(< or ≥ 1 year) 
1.175 1.842 .407 3.237
Cannabis Use 
(< or ≥ 1 year) 
.638 .488 1.705 1.892
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n = 199 
  
Hold-back sub-sample (n = 55) 
   
Parameter  
 
Estimate 
 
SE 
 
Wald χ 2 
 
Odds  
 
Ratio 
 
Parameter  
 
Estimate 
 
 
SE 
 
Wald χ 2 
 
Odds  
 
Ratio 
PAI-DRG 
(< or ≥ 70) 
.952         .380 6.268** 2.590 .129 .682 .036 1.137
PICTS-HIS 
(< or ≥ 60) 
.330         
       
.358 .849 1.391
Constant .523 .287 3.310 1.687
Note. PAI-DRG = Personality Assessment Inventory – Drug Problems; PICTS-HIS = Psychological Inventory of Criminal Thinking 
Styles-Historical. All predictor variables re-coded as described in text. 
**p < .05. 
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Table 13 
Logistic Regression Classification Table 
 
  
Predicted Group 
 
  
Completers 
 
 
Non-Completers 
 
Total 
 
Actual Completers 
 
124 
 
(89.9%)a 
 
14 
 
(10.1%) 
 
 
138 
 
(100%) 
Actual Non-completers 41 
(67.21%) 
20 
(32.8%)b 
61 
(100%) 
Note. a Sensitivity. b Specificity. 
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Table 14 
Discriminant Function Analysis Classification Table 
  
Predicted Group Membership 
 
  
Completers 
 
Non-Completers 
 
Total 
Completers 129 
(93.5%)a 
9 
(6.5%) 
138 
(100%) 
Non-Completers 46 
(75.4%) 
15 
(24.6%)a 
61 
(100%) 
Note. aConditional hit-rate calculated at 72.4%. 
 
 
 
 
